#Sample_ID,ID,UCD_index,AMR_seq_pool,SeqNotes,microbiome_seq_pool,Group_num,Group,Sample_type,Time,microbiome_raw_paired_reads,microbiome_dada_asv,microbiome_dada_filtered_asv,AMR_raw_paired_reads,AMR_QC_paired_reads,AMR_filter_removed,AMR_filter_proportion,AMR_nonhost_paired_reads,Pair_ID,Pen_name,New_name,Date,Project,DOF,DOF_float,DOF_cat,DOF_categories,Feedlot,Feedlot_cat,Feedlot_categories,Second_DOF,PEN.ID,Arrival_AnimalID,num_tx,Third_DOF,First_tx_DOF,Last_tx_DOF,Days_since_tx,Tx_time_cat,second_TimeCat,PEN.ID_num,DaysFromSampleToFirstTx,Total_ADD,Total_feed_ADD,Total_parenteral_ADD,total_tetracycline_ADD,total_MLS_ADD,feed_tetracycline_ADD,feed_MLS_ADD,parenteral_betalactams_ADD,parenteral_MLS_ADD,parenteral_phenicol_ADD,parenteral_fluoroquinolones_ADD,parenteral_sulfonamide_ADD,parenteral_tetracycline_ADD,Any.Parenteral.Drug,Total.parenteral.ADDs,Total_ADD_category,total_tetracycline_ADD_category,parenteral_tetracycline_ADD_category,feed_tetracycline_ADD_category,total_MLS_ADD_category,parenteral_MLS_ADD_category,feed_MLS_ADD_category,parenteral_betalactams_ADD_category,parenteral_phenicol_ADD_category,parenteral_fluoroquinolones_ADD_category,parenteral_sulfonamide_ADD_category
IA1,IA1,AAGGACAC,Pool 6,,Pool 1,1,Individual - 1st time point,Individual,1st time point,140704,49101,49101,0,0,0,NA,0,Individual_1,31012261,,,Project_3,1,1,1,DOF_1,31,Feedlot_31(N=13),Feedlot_31,78,Pen_310211,31012261,5,NA,0,0,0,Late,3,310211,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA10,IA10,ACCACTGT,Pool 6,,Pool 1,2,Individual - 1st time point,Individual,1st time point,156473,39054,39054,0,0,0,NA,0,Individual_2,42010789,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,88,Pen_420108,42010789,2,NA,0,0,0,Late,3,420108,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA11,IA11,GTACGCAA,Pool 6,,Pool 1,3,Individual - 1st time point,Individual,1st time point,151460,38339,38339,0,0,0,NA,0,Individual_3,42011228,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,83,Pen_420118,42011228,1,NA,0,0,0,Metaphylaxis,3,420118,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA12,IA12,AGTACAAG,Pool 6,,Pool 1,4,Individual - 1st time point,Individual,1st time point,150609,38428,38428,0,0,0,NA,0,Individual_4,42011266,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,83,Pen_420118,42011266,1,NA,0,0,0,Metaphylaxis,3,420118,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA13,IA13,CGACACAC,Pool 3,,Pool 1,5,Individual - 1st time point,Individual,1st time point,143444,41094,41094,6885106,6770930,2631898,0.38225962,4253208,Individual_5,42011317,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,83,Pen_420118,42011317,1,NA,0,0,0,Metaphylaxis,3,420118,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA14,IA14,ACATTGGC,Pool 6,,Pool 1,6,Individual - 1st time point,Individual,1st time point,154019,46522,46516,0,0,0,NA,0,Individual_6,42011330,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,83,Pen_420118,42011330,1,NA,0,0,0,Metaphylaxis,3,420118,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA15,IA15,GTGTTCTA,Pool 3,,Pool 1,7,Individual - 1st time point,Individual,1st time point,157856,41219,41195,13336698,12767024,2284528,0.171296373,11052170,Individual_7,42011332,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,83,Pen_420118,42011332,1,NA,0,0,0,Metaphylaxis,3,420118,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA16,IA16,CTAAGGTC,Pool 3,,Pool 1,8,Individual - 1st time point,Individual,1st time point,149815,35381,35381,18194281,17000763,2700726,0.148438182,15493555,Individual_8,42011408,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,83,Pen_420118,42011408,2,NA,0,0,0,Late,3,420118,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA17,IA17,ATTGAGGA,Pool 6,,Pool 1,9,Individual - 1st time point,Individual,1st time point,144616,36912,36912,0,0,0,NA,0,Individual_9,42011598,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,83,Pen_420118,42011598,1,NA,0,0,0,Metaphylaxis,3,420118,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA19,IA19,AACTCACC,Pool 2,,Pool 3,10,Individual - 1st time point,Individual,1st time point,122561,33900,33887,22268461,21756652,8477613,0.380700444,13790848,Individual_10,42011796,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,82,Pen_420119,42011796,1,NA,0,0,0,Metaphylaxis,3,420119,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA2,IA2,GACAGTGC,Pool 1,,Pool 1,11,Individual - 1st time point,Individual,1st time point,149420,43389,43389,3113837,3045174,994282,0.31931087,2119555,Individual_11,31012405,,,Project_3,1,1,1,DOF_1,31,Feedlot_31(N=13),Feedlot_31,77,Pen_310214,31012405,1,NA,0,0,0,Metaphylaxis,3,310214,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA23,IA23,GCTAACGA,Pool 2,,Pool 1,12,Individual - 1st time point,Individual,1st time point,146311,36310,36310,23756211,23046236,7637387,0.321490115,16118824,Individual_12,42012083,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,90,Pen_420123,42012083,1,NA,0,0,0,Metaphylaxis,3,420123,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA24,IA24,CAATGGAA,Pool 3,,Pool 1,13,Individual - 1st time point,Individual,1st time point,154089,44938,44938,12163267,11817805,3322512,0.273159506,8840755,Individual_13,42012099,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,90,Pen_420123,42012099,1,NA,0,0,0,Metaphylaxis,3,420123,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA27,IA27,#N/A,Pool 3,Couldnâ€™t find seq pool,Pool 1,14,Individual - 1st time point,Individual,1st time point,143781,35636,35636,0,0,0,NA,0,Individual_14,42012235,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,89,Pen_420123,42012235,1,NA,0,0,0,Metaphylaxis,3,420123,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA29,IA29,ATCCTGTA,Pool 1,,Pool 3,15,Individual - 1st time point,Individual,1st time point,125618,47385,47376,17066935,16648607,4158204,0.243640935,12908731,Individual_15,42012666,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,83,Pen_420126,42012666,1,NA,0,0,0,Metaphylaxis,3,420126,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA3,IA3,ATCATTCC,Pool 6,,Pool 1,16,Individual - 1st time point,Individual,1st time point,112200,32641,32641,0,0,0,NA,0,Individual_16,31012661,,,Project_3,1,1,1,DOF_1,31,Feedlot_31(N=13),Feedlot_31,75,Pen_310218,31012661,1,NA,0,0,0,Metaphylaxis,3,310218,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA30,IA30,CTGTAGCC,Pool 1,,Pool 1,17,Individual - 1st time point,Individual,1st time point,154982,39248,39248,9717604,9507432,2997004,0.308409768,6720600,Individual_17,42012786,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,81,Pen_420126,42012786,1,NA,0,0,0,Metaphylaxis,3,420126,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA32,IA32,GCTCGGTA,Pool 1,,Pool 1,18,Individual - 1st time point,Individual,1st time point,151680,38199,38199,10408872,10215177,3965249,0.380948964,6443623,Individual_18,42012980,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,85,Pen_420128,42012980,1,NA,0,0,0,Metaphylaxis,3,420128,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA33,IA33,ACACGACC,Pool 1,,Pool 1,19,Individual - 1st time point,Individual,1st time point,119859,37598,37598,10126581,9934145,3159235,0.311974496,6967346,Individual_19,21012354,,,Project_3,1,1,1,DOF_1,21,Feedlot_21(N=11),Feedlot_21,133,Pen_210362,21012354,1,NA,0,0,0,Metaphylaxis,4,210362,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA34,IA34,AGTCACTA,Pool 1,,Pool 1,20,Individual - 1st time point,Individual,1st time point,147866,51637,51637,13113540,12821912,3843454,0.2930905,9270086,Individual_20,21012503,,,Project_3,1,1,1,DOF_1,21,Feedlot_21(N=11),Feedlot_21,133,Pen_210361,21012503,1,NA,0,0,0,Metaphylaxis,4,210361,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA35,IA35,AGTACAAG,Pool 1,,Pool 1,21,Individual - 1st time point,Individual,1st time point,145085,44065,44065,19096271,18559078,3627998,0.189984631,15468273,Individual_21,21012521,,,Project_3,1,1,1,DOF_1,21,Feedlot_21(N=11),Feedlot_21,133,Pen_210361,21012521,2,NA,0,0,0,Early,4,210361,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA38,IA38,ACATTGGC,Pool 1,,Pool 1,22,Individual - 1st time point,Individual,1st time point,150252,25769,25769,16998160,16673804,6128777,0.360555319,10869383,Individual_22,21013044,,,Project_3,1,1,1,DOF_1,21,Feedlot_21(N=11),Feedlot_21,141,Pen_210379,21013044,1,NA,0,0,0,Metaphylaxis,4,210379,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA39,IA39,ATTGAGGA,Pool 1,,Pool 5,23,Individual - 1st time point,Individual,1st time point,176334,45404,45404,16517780,16053959,3767814,0.228106562,12749966,Individual_23,21013391,,,Project_3,1,1,1,DOF_1,21,Feedlot_21(N=11),Feedlot_21,131,Pen_210389,21013391,1,NA,0,0,0,Metaphylaxis,4,210389,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA4,IA4,AGCCATGC,Pool 6,,Pool 1,24,Individual - 1st time point,Individual,1st time point,146792,38461,38461,0,0,0,NA,0,Individual_24,5012005,,,Project_3,1,1,1,DOF_1,5,Feedlot_5(N=16),Feedlot_5,79,Pen_50154,5012005,1,NA,0,0,0,Late,3,50154,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA40,IA40,GTCGTAGA,Pool 1,,Pool 1,25,Individual - 1st time point,Individual,1st time point,144712,38655,38655,17364153,16781053,2838164,0.163449608,14525989,Individual_25,31015454,,,Project_3,1,1,1,DOF_1,31,Feedlot_31(N=13),Feedlot_31,118,Pen_310301,31015454,2,NA,0,0,0,Early,3,310301,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA41,IA41,AGAGTCAA,Pool 1,,Pool 1,26,Individual - 1st time point,Individual,1st time point,149849,35817,35817,18498535,17943350,3936245,0.21278685,14562290,Individual_26,31015518,,,Project_3,1,1,1,DOF_1,31,Feedlot_31(N=13),Feedlot_31,118,Pen_310301,31015518,1,NA,0,0,0,Early,3,310301,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA43,IA43,ACGTATCA,Pool 1,,Pool 1,27,Individual - 1st time point,Individual,1st time point,159747,38591,38591,16760676,16262775,3010285,0.179604033,13750391,Individual_27,31015612,,,Project_3,1,1,1,DOF_1,31,Feedlot_31(N=13),Feedlot_31,115,Pen_310301,31015612,1,NA,0,0,0,Metaphylaxis,3,310301,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA44,IA44,#N/A,Pool 2,Couldnâ€™t find seq pool,Pool 1,28,Individual - 1st time point,Individual,1st time point,156667,36249,36249,0,0,0,NA,0,Individual_28,21013176,,,Project_3,1,1,1,DOF_1,21,Feedlot_21(N=11),Feedlot_21,141,Pen_210380,21013176,0,NA,0,0,0,None,4,210380,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA45,IA45,CCGACAAC,Pool 1,,Pool 1,29,Individual - 1st time point,Individual,1st time point,156332,38316,38316,16660388,16180543,3418551,0.205190359,13241837,Individual_29,5013455,,,Project_3,1,1,1,DOF_1,5,Feedlot_5(N=16),Feedlot_5,142,Pen_50176,5013455,1,NA,0,0,0,Metaphylaxis,4,50176,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA46,IA46,GCCAAGAC,Pool 3,,Pool 1,30,Individual - 1st time point,Individual,1st time point,147495,33427,33427,5213762,5008062,1787790,0.342898276,3425972,Individual_30,5013532,,,Project_3,1,1,1,DOF_1,5,Feedlot_5(N=16),Feedlot_5,142,Pen_50176,5013532,1,NA,0,0,0,Metaphylaxis,4,50176,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA47,IA47,GACTAGTA,Pool 3,,Pool 1,31,Individual - 1st time point,Individual,1st time point,154382,31687,31687,11903784,11545274,3141136,0.2638771,8762648,Individual_31,5013565,,,Project_3,1,1,1,DOF_1,5,Feedlot_5(N=16),Feedlot_5,142,Pen_50176,5013565,1,NA,0,0,0,Metaphylaxis,4,50176,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA49,IA49,ATTGGCTC,Pool 3,,Pool 1,32,Individual - 1st time point,Individual,1st time point,145691,32027,32027,13351222,12911886,3954224,0.296169444,9396998,Individual_32,5013646,,,Project_3,1,1,1,DOF_1,5,Feedlot_5(N=16),Feedlot_5,141,Pen_50176,5013646,1,NA,0,0,0,Metaphylaxis,4,50176,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA5,IA5,CCGTGAGA,Pool 3,,Pool 1,33,Individual - 1st time point,Individual,1st time point,157802,55471,55471,18392226,17426039,3948682,0.21469299,14443544,Individual_33,31013266,,,Project_3,1,1,1,DOF_1,31,Feedlot_31(N=13),Feedlot_31,66,Pen_310233,31013266,1,NA,0,0,0,Metaphylaxis,2,310233,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA50,IA50,#N/A,Pool 3,Couldnâ€™t find seq pool,Pool 1,34,Individual - 1st time point,Individual,1st time point,141149,38349,38349,0,0,0,NA,0,Individual_34,5013727,,,Project_3,1,1,1,DOF_1,5,Feedlot_5(N=16),Feedlot_5,144,Pen_50178,5013727,1,NA,0,0,0,Metaphylaxis,4,50178,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA51,IA51,AGCACCTC,Pool 3,,Pool 1,35,Individual - 1st time point,Individual,1st time point,151384,32223,32223,9908348,9684955,2993350,0.302103842,6914998,Individual_35,5013908,,,Project_3,1,1,1,DOF_1,5,Feedlot_5(N=16),Feedlot_5,144,Pen_50178,5013908,1,NA,0,0,0,Metaphylaxis,4,50178,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA52,IA52,GAGCTGAA,Pool 2,,Pool 1,36,Individual - 1st time point,Individual,1st time point,156177,30714,30714,17245535,16507286,3781204,0.219256984,13464331,Individual_36,31016140,,,Project_3,1,1,1,DOF_1,31,Feedlot_31(N=13),Feedlot_31,69,Pen_310315,31016140,1,NA,0,0,0,Metaphylaxis,2,310315,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA53,IA53,AAACATCG,Pool 2,,Pool 1,37,Individual - 1st time point,Individual,1st time point,147787,34938,34938,8882200,8637459,3187280,0.358839026,5694920,Individual_37,5014488,,,Project_3,1,1,1,DOF_1,5,Feedlot_5(N=16),Feedlot_5,70,Pen_50190,5014488,1,NA,0,0,0,Metaphylaxis,2,50190,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA54,IA54,GAGTTAGC,Pool 3,,Pool 1,38,Individual - 1st time point,Individual,1st time point,101543,24539,24539,13789787,13321816,3349338,0.242885405,10440449,Individual_38,5014736,,,Project_3,1,1,1,DOF_1,5,Feedlot_5(N=16),Feedlot_5,69,Pen_50190,5014736,1,NA,0,0,0,Metaphylaxis,2,50190,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA55,IA55,CGAACTTA,Pool 2,,Pool 1,39,Individual - 1st time point,Individual,1st time point,153294,33143,33143,13309205,12907268,5136177,0.38591163,8173028,Individual_39,5014754,,,Project_3,1,1,1,DOF_1,5,Feedlot_5(N=16),Feedlot_5,69,Pen_50190,5014754,1,NA,0,0,0,Metaphylaxis,2,50190,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA56,IA56,GTCTGTCA,Pool 3,,Pool 1,40,Individual - 1st time point,Individual,1st time point,150321,32255,32255,17291458,16393869,3038044,0.175696231,14253414,Individual_40,5014855,,,Project_3,1,1,1,DOF_1,5,Feedlot_5(N=16),Feedlot_5,70,Pen_50191,5014855,1,NA,0,0,0,Metaphylaxis,2,50191,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA57,IA57,AAGGACAC,Pool 3,,Pool 1,41,Individual - 1st time point,Individual,1st time point,158787,40613,40594,8521160,8087587,1716480,0.201437363,6804680,Individual_41,21012773,,,Project_3,1,1,1,DOF_1,21,Feedlot_21(N=11),Feedlot_21,171,Pen_210366,21012773,1,NA,0,0,0,Early,4,210366,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA58,IA58,GACAGTGC,Pool 3,,Pool 1,42,Individual - 1st time point,Individual,1st time point,108365,25008,25008,19504110,18654819,3025150,0.155103206,16478960,Individual_42,21014504,,,Project_3,1,1,1,DOF_1,21,Feedlot_21(N=11),Feedlot_21,78,Pen_210424,21014504,1,NA,0,0,0,Metaphylaxis,3,210424,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA6,IA6,#N/A,Pool 3,Couldnâ€™t find seq pool,Pool 1,43,Individual - 1st time point,Individual,1st time point,147032,40679,40679,0,0,0,NA,0,Individual_43,42010882,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,81,Pen_420117,42010882,2,NA,0,0,0,Late,3,420117,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA60,IA60,ATCATTCC,Pool 2,,Pool 1,44,Individual - 1st time point,Individual,1st time point,154506,34222,34222,19906054,18855981,3502890,0.175971089,16403164,Individual_44,21014055,Issue with not showing up on final exposure data,,Project_3,1,1,1,DOF_1,21,Feedlot_21(N=11),Feedlot_21,126,Pen_210416,21014055,0,NA,0,0,0,None,4,210416,NoTx,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA61,IA61,CTGGCATA,Pool 3,,Pool 1,45,Individual - 1st time point,Individual,1st time point,146339,28934,28934,14924071,14331765,2872346,0.192463973,12051725,Individual_45,21012293,,,Project_3,1,1,1,DOF_1,21,Feedlot_21(N=11),Feedlot_21,141,Pen_210360,21012293,1,NA,0,0,0,Metaphylaxis,4,210360,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA62,IA62,ACCTCCAA,Pool 2,,Pool 1,46,Individual - 1st time point,Individual,1st time point,123446,20943,20943,21391921,20864639,5706833,0.266775153,15685088,Individual_46,5014535,,,Project_3,1,1,1,DOF_1,5,Feedlot_5(N=16),Feedlot_5,70,Pen_50190,5014535,2,NA,0,0,0,Late,2,50190,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA63,IA63,GCGAGTAA,Pool 3,,Pool 1,47,Individual - 1st time point,Individual,1st time point,152160,31535,31535,12765482,12412086,3337974,0.261484369,9427508,Individual_47,42011425,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,83,Pen_420118,42011425,1,NA,0,0,0,Metaphylaxis,3,420118,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA64,IA64,ACTATGCA,Pool 3,,Pool 1,48,Individual - 1st time point,Individual,1st time point,140853,43935,43935,20723988,19896626,4999396,0.24123716,15724592,Individual_48,5013665,,,Project_3,1,1,1,DOF_1,5,Feedlot_5(N=16),Feedlot_5,141,Pen_50176,5013665,1,NA,0,0,0,Metaphylaxis,4,50176,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA65,IA65,CGGATTGC,Pool 3,,Pool 1,49,Individual - 1st time point,Individual,1st time point,156439,42519,42519,14756702,14118605,3476399,0.235581026,11280303,Individual_49,5014571,,,Project_3,1,1,1,DOF_1,5,Feedlot_5(N=16),Feedlot_5,70,Pen_50190,5014571,1,NA,0,0,0,Metaphylaxis,2,50190,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA66,IA66,AACTCACC,Pool 3,,Pool 3,50,Individual - 1st time point,Individual,1st time point,142067,44414,44414,14775648,14215617,3130327,0.211857172,11645321,Individual_50,31012391,,,Project_3,1,1,1,DOF_1,31,Feedlot_31(N=13),Feedlot_31,77,Pen_310214,31012391,1,NA,0,0,0,Metaphylaxis,1,310214,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA67,IA67,GCTAACGA,Pool 3,,Pool 1,51,Individual - 1st time point,Individual,1st time point,149940,44490,44490,12226238,11645032,2506935,0.205045493,9719303,Individual_51,31012598,,,Project_3,1,1,1,DOF_1,31,Feedlot_31(N=13),Feedlot_31,74,Pen_310218,31012598,1,NA,0,0,0,Metaphylaxis,3,310218,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA68,IA68,CAGATCTG,Pool 1,,Pool 1,52,Individual - 1st time point,Individual,1st time point,142477,54518,54518,13517390,13127797,2350786,0.173908277,11166604,Individual_52,31012556,,,Project_3,1,1,1,DOF_1,31,Feedlot_31(N=13),Feedlot_31,74,Pen_310218,31012556,1,NA,0,0,0,Metaphylaxis,3,310218,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA7,IA7,GCCACATA,Pool 6,,Pool 1,53,Individual - 1st time point,Individual,1st time point,154469,37497,37497,0,0,0,NA,0,Individual_53,42010065,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,108,Pen_420105,42010065,2,NA,0,0,0,Late,3,420105,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA70,IA70,ATCCTGTA,Pool 3,,Pool 1,54,Individual - 1st time point,Individual,1st time point,142826,47378,47378,18502435,18076053,4741121,0.256243084,13761314,Individual_54,5013889,,,Project_3,1,1,1,DOF_1,5,Feedlot_5(N=16),Feedlot_5,144,Pen_50178,5013889,1,NA,0,0,0,Metaphylaxis,4,50178,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA71,IA71,CTGTAGCC,Pool 3,,Pool 1,55,Individual - 1st time point,Individual,1st time point,159977,30807,30786,15735681,15329113,4073596,0.258876371,11662085,Individual_55,21012515,,,Project_3,1,1,1,DOF_1,21,Feedlot_21(N=11),Feedlot_21,133,Pen_210361,21012515,1,NA,0,0,0,Metaphylaxis,4,210361,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA72,IA72,GCTCGGTA,Pool 3,,Pool 1,56,Individual - 1st time point,Individual,1st time point,145745,42373,42373,17381438,16432568,3556213,0.204598319,13825225,Individual_56,5014934,,,Project_3,1,1,1,DOF_1,5,Feedlot_5(N=16),Feedlot_5,70,Pen_50191,5014934,1,NA,0,0,0,Metaphylaxis,2,50191,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA73,IA73,ACACGACC,Pool 3,,Pool 1,57,Individual - 1st time point,Individual,1st time point,150886,47370,47370,14601711,13958795,2648078,0.181353952,11953633,Individual_57,31012244,,,Project_3,1,1,1,DOF_1,31,Feedlot_31(N=13),Feedlot_31,78,Pen_310211,31012244,1,NA,0,0,0,Metaphylaxis,3,310211,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA74,IA74,AGTCACTA,Pool 3,,Pool 1,58,Individual - 1st time point,Individual,1st time point,152937,39627,39614,17679730,16867383,3644727,0.206152865,14035003,Individual_58,31015354,Issue with not showing up on final exposure data,,Project_3,1,1,1,DOF_1,31,Feedlot_31(N=13),Feedlot_31,79,Pen_310263,31015354,2,NA,0,0,0,Late,3,310263,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA75,IA75,AACGCTTA,Pool 1,,Pool 1,59,Individual - 1st time point,Individual,1st time point,146274,49445,49445,15353917,14886637,3010592,0.196079737,12343325,Individual_59,42009541,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,92,Pen_420093,42009541,1,NA,0,0,0,Metaphylaxis,3,420093,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IA76,IA76,GGAGAACA,Pool 3,,Pool 1,60,Individual - 1st time point,Individual,1st time point,155443,50658,50658,14602926,14057362,3877431,0.265524252,10725495,Individual_60,42012115,,,Project_3,1,1,1,DOF_1,42,Feedlot_42(N=20),Feedlot_42,90,Pen_420123,42012115,1,NA,0,0,0,Metaphylaxis,3,420123,#N/A,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
IE1,IE1,ACAGCAGA,Pool 3,,Pool 1,1,Individual - 2nd time point,Individual,2nd time point,156275,48140,48140,13806648,13089954,3215026,0.23286072,10591622,Individual_1,8/26/2009,,,Project_3,78,78,3,DOF_3,31,Feedlot_31(N=13),Feedlot_31,78,Pen_310211,31012261,5,NA,0,29,49,Late,3,310211,#N/A,11.6667,4.6667,7,8.6667,0,4.6667,0,0,0,0,0,3,4,YES,7,Medium total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,Low parenteral sulfonamide exposure
IE10,IE10,GTCTGTCA,Pool 1,,Pool 5,2,Individual - 2nd time point,Individual,2nd time point,208020,41463,41463,21193832,20575827,4875605,0.230048299,16318227,Individual_2,10/8/2009,,,Project_3,88,88,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,88,Pen_420108,42010789,2,NA,0,5,83,Late,3,420108,#N/A,11.7222,5.7222,6,8.7222,3,5.7222,0,0,3,0,0,0,3,YES,6,Medium total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Low feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE11,IE11,CTAAGGTC,Pool 6,,Pool 2,3,Individual - 2nd time point,Individual,2nd time point,146587,34103,34103,0,0,0,NA,0,Individual_47,10/15/2009,,,Project_3,83,83,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,83,Pen_420118,42011425,1,NA,0,0,83,Metaphylaxis,3,420118,#N/A,21.6111,18.6111,3,18.6111,3,18.6111,0,0,3,0,0,0,0,YES,3,High total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE12,IE12,CCGTGAGA,Pool 6,,Pool 1,4,Individual - 2nd time point,Individual,2nd time point,156433,36436,36436,0,0,0,NA,0,Individual_3,10/15/2009,,,Project_3,83,83,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,83,Pen_420118,42011228,1,NA,0,0,83,Metaphylaxis,3,420118,#N/A,21.6111,18.6111,3,18.6111,3,18.6111,0,0,3,0,0,0,0,YES,3,High total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE13,IE13,CGAACTTA,Pool 6,,Pool 1,5,Individual - 2nd time point,Individual,2nd time point,106351,24930,24930,0,0,0,NA,0,Individual_4,10/15/2009,,,Project_3,83,83,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,83,Pen_420118,42011266,1,NA,0,0,83,Metaphylaxis,3,420118,#N/A,21.6111,18.6111,3,18.6111,3,18.6111,0,0,3,0,0,0,0,YES,3,High total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE14,IE14,GATAGACA,Pool 6,,Pool 1,6,Individual - 2nd time point,Individual,2nd time point,145371,50178,50178,0,0,0,NA,0,Individual_5,10/15/2009,,,Project_3,83,83,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,83,Pen_420118,42011317,1,NA,0,0,83,Metaphylaxis,3,420118,#N/A,21.6111,18.6111,3,18.6111,3,18.6111,0,0,3,0,0,0,0,YES,3,High total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE15,IE15,GCCAAGAC,Pool 1,,Pool 1,7,Individual - 2nd time point,Individual,2nd time point,146249,43976,43976,19685658,19086296,3956401,0.200978855,15729257,Individual_6,10/15/2009,,,Project_3,83,83,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,83,Pen_420118,42011330,1,NA,0,0,83,Metaphylaxis,3,420118,#N/A,21.6111,18.6111,3,18.6111,3,18.6111,0,0,3,0,0,0,0,YES,3,High total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE16,IE16,GACTAGTA,Pool 1,,Pool 2,8,Individual - 2nd time point,Individual,2nd time point,154160,53384,53384,13743238,13336915,3034579,0.220805243,10708659,Individual_7,10/15/2009,,,Project_3,83,83,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,83,Pen_420118,42011332,1,NA,0,0,83,Metaphylaxis,3,420118,#N/A,21.6111,18.6111,3,18.6111,3,18.6111,0,0,3,0,0,0,0,YES,3,High total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE17,IE17,CTGGCATA,Pool 1,,Pool 1,9,Individual - 2nd time point,Individual,2nd time point,171258,49272,49272,19059692,18440960,4370377,0.229299456,14689315,Individual_8,10/15/2009,,,Project_3,83,83,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,83,Pen_420118,42011408,2,NA,0,50,33,Late,3,420118,#N/A,24.6111,18.6111,6,18.6111,3,18.6111,0,0,3,3,0,0,0,YES,6,High total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,Low parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE18,IE18,ACCTCCAA,Pool 1,,Pool 1,10,Individual - 2nd time point,Individual,2nd time point,157239,46995,46995,16785654,16273548,3849520,0.22933393,12936134,Individual_9,10/15/2009,,,Project_3,83,83,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,83,Pen_420118,42011598,1,NA,0,0,83,Metaphylaxis,3,420118,#N/A,21.6111,18.6111,3,18.6111,3,18.6111,0,0,3,0,0,0,0,YES,3,High total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE2,IE2,AGCAGGAA,Pool 6,,Pool 2,11,Individual - 2nd time point,Individual,2nd time point,159866,42133,42133,0,0,0,NA,0,Individual_11,8/27/2009,,,Project_3,77,77,3,DOF_3,31,Feedlot_31(N=13),Feedlot_31,77,Pen_310214,31012405,1,NA,0,0,77,Metaphylaxis,3,310214,#N/A,6.2778,4.2778,2,6.2778,0,4.2778,0,0,0,0,0,0,2,YES,2,Low total ADD exposure,Low total tetracycline exposure,Low parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE20,IE20,GCGAGTAA,Pool 1,,Pool 1,12,Individual - 2nd time point,Individual,2nd time point,156935,47813,47813,18970820,18462433,5454359,0.287513086,13516461,Individual_10,10/16/2009,,,Project_3,82,82,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,82,Pen_420119,42011796,1,NA,0,0,82,Metaphylaxis,3,420119,#N/A,17.6111,14.6111,3,14.6111,3,14.6111,0,0,3,0,0,0,0,YES,3,Medium total ADD exposure,Medium total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE24,IE24,ACTATGCA,Pool 1,,Pool 1,13,Individual - 2nd time point,Individual,2nd time point,159987,62936,62936,21504949,20868588,645977,0.030038527,20858972,Individual_12,10/28/2009,,,Project_3,90,90,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,90,Pen_420123,42012083,1,NA,0,0,90,Metaphylaxis,3,420123,#N/A,18.0556,15.0556,3,15.0556,3,15.0556,0,0,3,0,0,0,0,YES,3,Medium total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE25,IE25,CGGATTGC,Pool 1,,Pool 1,14,Individual - 2nd time point,Individual,2nd time point,142662,42072,42072,17953607,17392219,810161,0.04512525,17143446,Individual_13,10/28/2009,,,Project_3,90,90,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,90,Pen_420123,42012099,1,NA,0,0,90,Metaphylaxis,3,420123,#N/A,18.0556,15.0556,3,15.0556,3,15.0556,0,0,3,0,0,0,0,YES,3,Medium total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE28,IE28,CGCTGATC,Pool 1,,Pool 1,15,Individual - 2nd time point,Individual,2nd time point,143921,48452,48452,12257958,11903945,2799208,0.228358426,9458750,Individual_14,10/29/2009,,,Project_3,89,89,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,89,Pen_420123,42012235,1,NA,0,0,89,Metaphylaxis,3,420123,#N/A,18.0556,15.0556,3,15.0556,3,15.0556,0,0,3,0,0,0,0,YES,3,Medium total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE3,IE3,GAGCTGAA,Pool 6,,Pool 2,16,Individual - 2nd time point,Individual,2nd time point,153190,48370,48370,0,0,0,NA,0,Individual_16,9/3/2009,,,Project_3,75,75,3,DOF_3,31,Feedlot_31(N=13),Feedlot_31,75,Pen_310218,31012661,1,NA,0,0,75,Metaphylaxis,3,310218,#N/A,6.2222,4.2222,2,6.2222,0,4.2222,0,0,0,0,0,0,2,YES,2,Low total ADD exposure,Low total tetracycline exposure,Low parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE30,IE30,GGTGCGAA,Pool 1,,Pool 2,17,Individual - 2nd time point,Individual,2nd time point,159772,48234,48234,15142948,14667207,3258711,0.215196605,11884237,Individual_15,11/11/2009,,,Project_3,83,83,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,83,Pen_420126,42012666,1,NA,0,0,83,Metaphylaxis,3,420126,#N/A,18.7778,15.7778,3,15.7778,3,15.7778,0,0,3,0,0,0,0,YES,3,Medium total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE31,IE31,CCTAATCC,Pool 1,,Pool 1,18,Individual - 2nd time point,Individual,2nd time point,143922,36276,36276,17733210,17208323,4117347,0.232182837,13615863,Individual_17,11/13/2009,,,Project_3,81,81,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,81,Pen_420126,42012786,1,NA,0,0,81,Metaphylaxis,3,420126,#N/A,18.7778,15.7778,3,15.7778,3,15.7778,0,0,3,0,0,0,0,YES,3,Medium total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE33,IE33,CTGAGCCA,Pool 1,,Pool 1,19,Individual - 2nd time point,Individual,2nd time point,150166,41449,41449,18042939,17531530,4832366,0.267825879,13210573,Individual_18,11/17/2009,,,Project_3,85,85,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,85,Pen_420128,42012980,1,NA,0,0,85,Metaphylaxis,3,420128,#N/A,21.7222,18.7222,3,18.7222,3,18.7222,0,0,3,0,0,0,0,YES,3,High total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE34,IE34,AGCCATGC,Pool 1,,Pool 2,20,Individual - 2nd time point,Individual,2nd time point,142918,53187,53187,17223598,16669061,3037125,0.176335107,14186473,Individual_19,10/8/2009,,,Project_3,133,133,4,DOF_4,21,Feedlot_21(N=11),Feedlot_21,133,Pen_210362,21012354,1,NA,0,0,133,Metaphylaxis,4,210362,#N/A,10.0444,7.0444,3,9.9444,0.1,6.9444,0.1,0,0,0,0,0,3,YES,3,Medium total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE35,IE35,GTACGCAA,Pool 1,,Pool 2,21,Individual - 2nd time point,Individual,2nd time point,140318,46463,46463,18471701,17908391,3678179,0.199125083,14793522,Individual_20,10/8/2009,,,Project_3,133,133,4,DOF_4,21,Feedlot_21(N=11),Feedlot_21,133,Pen_210361,21012503,1,NA,0,0,133,Metaphylaxis,4,210361,#N/A,10.0444,7.0444,3,9.9444,0.1,6.9444,0.1,0,0,0,0,0,3,YES,3,Medium total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE36,IE36,ATGCCTAA,Pool 1,,Pool 1,22,Individual - 2nd time point,Individual,2nd time point,152489,38721,38721,13094397,12708668,2966698,0.226562399,10127699,Individual_21,10/8/2009,,,Project_3,133,133,4,DOF_4,21,Feedlot_21(N=11),Feedlot_21,133,Pen_210361,21012521,2,NA,0,23,110,Early,4,210361,#N/A,13.0444,7.0444,6,9.9444,3.1,6.9444,0.1,0,3,0,0,0,3,YES,6,Medium total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE37,IE37,GAATCTGA,Pool 1,,Pool 2,23,Individual - 2nd time point,Individual,2nd time point,150312,37912,37912,14245098,13786201,2809813,0.197247713,11435285,Individual_45,10/8/2009,,,Project_3,141,141,4,DOF_4,21,Feedlot_21(N=11),Feedlot_21,141,Pen_210360,21012293,1,NA,0,0,141,Metaphylaxis,4,210360,#N/A,10.4889,7.4889,3,10.3889,0.1,7.3889,0.1,0,0,0,0,0,3,YES,3,Medium total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE39,IE39,AACGTGAT,Pool 1,,Pool 2,24,Individual - 2nd time point,Individual,2nd time point,103412,33155,33155,19329174,18712524,3341441,0.172870346,15987733,Individual_22,10/26/2009,,,Project_3,141,141,4,DOF_4,21,Feedlot_21(N=11),Feedlot_21,141,Pen_210379,21013044,1,NA,0,0,141,Metaphylaxis,4,210379,#N/A,10.6306,7.6306,3,10.5556,0.075,7.5556,0.075,0,0,0,0,0,3,YES,3,Medium total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE4,IE4,GTCGTAGA,Pool 6,,Pool 5,25,Individual - 2nd time point,Individual,2nd time point,199675,65270,65270,0,0,0,NA,0,Individual_24,9/1/2009,,,Project_3,79,79,3,DOF_3,5,Feedlot_5(N=16),Feedlot_5,79,Pen_50154,5012005,1,NA,21,21,58,Late,3,50154,#N/A,7.2778,4.2778,3,4.2778,3,4.2778,0,0,3,0,0,0,0,YES,3,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE40,IE40,CACTTCGA,Pool 1,,Pool 2,26,Individual - 2nd time point,Individual,2nd time point,136214,35955,35955,14439790,13954691,2648240,0.183398789,11791550,Individual_23,11/5/2009,,,Project_3,131,131,4,DOF_4,21,Feedlot_21(N=11),Feedlot_21,131,Pen_210389,21013391,1,NA,0,0,131,Metaphylaxis,4,210389,#N/A,9.9764,6.9764,3,9.8889,0.0875,6.8889,0.0875,0,0,0,0,0,3,YES,3,Low total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE41,IE41,ATTGGCTC,Pool 1,,Pool 1,27,Individual - 2nd time point,Individual,2nd time point,142115,45533,45533,16977386,16555902,4789134,0.282089009,12188252,Individual_25,11/18/2009,,,Project_3,118,118,3,DOF_3,31,Feedlot_31(N=13),Feedlot_31,118,Pen_310301,31015454,2,NA,1,4,114,Early,3,310301,#N/A,12.5556,6.5556,6,9.5556,0,6.5556,0,0,0,3,0,0,3,YES,6,Medium total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,Low parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE42,IE42,GATGAATC,Pool 1,,Pool 1,28,Individual - 2nd time point,Individual,2nd time point,158718,49242,49242,16845632,16310340,2725810,0.161811086,14119822,Individual_26,11/18/2009,,,Project_3,118,118,3,DOF_3,31,Feedlot_31(N=13),Feedlot_31,118,Pen_310301,31015518,1,NA,1,1,117,Early,3,310301,#N/A,9.5556,6.5556,3,9.5556,0,6.5556,0,0,0,0,0,0,3,YES,3,Low total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE43,IE43,AGCAGGAA,Pool 1,,Pool 2,29,Individual - 2nd time point,Individual,2nd time point,105581,33674,33674,17868842,17259648,3419145,0.191346759,14449697,Individual_27,11/21/2009,,,Project_3,115,115,3,DOF_3,31,Feedlot_31(N=13),Feedlot_31,115,Pen_310301,31015612,1,NA,0,0,115,Metaphylaxis,3,310301,#N/A,9.5556,6.5556,3,9.5556,0,6.5556,0,0,0,0,0,0,3,YES,3,Low total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE44,IE44,GAGCTGAA,Pool 1,,Pool 2,30,Individual - 2nd time point,Individual,2nd time point,152088,40244,40244,15882170,15351204,2921161,0.18392707,12961009,Individual_28,10/27/2009,,,Project_3,141,141,4,DOF_4,21,Feedlot_21(N=11),Feedlot_21,141,Pen_210380,21013176,0,NA,None,None,None,None,4,210380,#N/A,7.575,7.575,0,7.5,0.075,7.5,0.075,0,0,0,0,0,0,NO,0,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE45,IE45,AAACATCG,Pool 1,,Pool 2,31,Individual - 2nd time point,Individual,2nd time point,145722,36864,36864,14104305,13658161,2950066,0.209160678,11154239,Individual_29,10/27/2009,,,Project_3,142,142,4,DOF_4,5,Feedlot_5(N=16),Feedlot_5,142,Pen_50176,5013455,1,NA,0,0,142,Metaphylaxis,4,50176,#N/A,18.8889,15.8889,3,15.8889,3,15.8889,0,0,3,0,0,0,0,YES,3,Medium total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE46,IE46,GAGTTAGC,Pool 1,,Pool 2,32,Individual - 2nd time point,Individual,2nd time point,131935,43176,43176,9738094,9407972,1596650,0.16395919,8141444,Individual_30,10/27/2009,,,Project_3,142,142,4,DOF_4,5,Feedlot_5(N=16),Feedlot_5,142,Pen_50176,5013532,1,NA,0,0,142,Metaphylaxis,4,50176,#N/A,18.8889,15.8889,3,15.8889,3,15.8889,0,0,3,0,0,0,0,YES,3,Medium total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE47,IE47,CGAACTTA,Pool 1,,Pool 2,33,Individual - 2nd time point,Individual,2nd time point,156928,49793,49793,14187083,13752544,554593,0.039091404,13632490,Individual_31,10/27/2009,,,Project_3,142,142,4,DOF_4,5,Feedlot_5(N=16),Feedlot_5,142,Pen_50176,5013565,1,NA,0,0,142,Metaphylaxis,4,50176,#N/A,18.8889,15.8889,3,15.8889,3,15.8889,0,0,3,0,0,0,0,YES,3,Medium total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE49,IE49,CGCTGATC,Pool 6,,Pool 2,34,Individual - 2nd time point,Individual,2nd time point,149310,42470,42461,0,0,0,NA,0,Individual_32,10/28/2009,,,Project_3,141,141,4,DOF_4,5,Feedlot_5(N=16),Feedlot_5,141,Pen_50176,5013646,1,NA,0,0,141,Metaphylaxis,4,50176,#N/A,18.8889,15.8889,3,15.8889,3,15.8889,0,0,3,0,0,0,0,YES,3,Medium total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE5,IE5,GAGTTAGC,Pool 6,,Pool 2,35,Individual - 2nd time point,Individual,2nd time point,111036,31287,31287,0,0,0,NA,0,Individual_33,9/23/2009,,,Project_3,66,66,2,DOF_2,31,Feedlot_31(N=13),Feedlot_31,66,Pen_310233,31013266,1,NA,0,0,66,Metaphylaxis,2,310233,#N/A,3.72584,3.7222,0.00364,3.7222,0.00364,3.7222,0,0,0.00364,0,0,0,0,YES,0.00364,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,Low total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE50,IE50,GGTGCGAA,Pool 6,,Pool 2,36,Individual - 2nd time point,Individual,2nd time point,117846,31907,31907,0,0,0,NA,0,Individual_34,10/29/2009,,,Project_3,144,144,2,DOF_2,5,Feedlot_5(N=16),Feedlot_5,144,Pen_50178,5013727,1,NA,0,0,144,Metaphylaxis,4,50178,#N/A,19,16,3,16,3,16,0,0,3,0,0,0,0,YES,3,High total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE51,IE51,CCTAATCC,Pool 6,,Pool 1,37,Individual - 2nd time point,Individual,2nd time point,140672,35001,35001,0,0,0,NA,0,Individual_35,10/29/2009,,,Project_3,144,144,2,DOF_2,5,Feedlot_5(N=16),Feedlot_5,144,Pen_50178,5013908,1,NA,0,0,144,Metaphylaxis,4,50178,#N/A,19,16,3,16,3,16,0,0,3,0,0,0,0,YES,3,High total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE52,IE52,GATAGACA,Pool 1,,Pool 1,38,Individual - 2nd time point,Individual,2nd time point,141109,53673,53673,17025545,16500001,3410820,0.200335437,13614725,Individual_36,1/13/2010,,,Project_3,69,69,2,DOF_2,31,Feedlot_31(N=13),Feedlot_31,69,Pen_310315,31016140,1,NA,0,0,69,Metaphylaxis,2,310315,#N/A,5.8889,3.8889,2,5.8889,0,3.8889,0,0,0,0,0,0,2,YES,2,Low total ADD exposure,Low total tetracycline exposure,Low parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE53,IE53,AAGGACAC,Pool 1,,Pool 1,39,Individual - 2nd time point,Individual,2nd time point,151051,36111,36082,21767716,21195846,6049619,0.277917031,15718097,Individual_37,1/13/2010,,,Project_3,70,70,2,DOF_2,5,Feedlot_5(N=16),Feedlot_5,70,Pen_50190,5014488,1,NA,0,0,70,Metaphylaxis,2,50190,#N/A,7.1667,4.1667,3,7.1667,0,4.1667,0,0,0,0,0,0,3,YES,3,Low total ADD exposure,Low total tetracycline exposure,Medium parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE54,IE54,ATCATTCC,Pool 1,,Pool 1,40,Individual - 2nd time point,Individual,2nd time point,158845,47258,47253,17169236,16645905,3774781,0.219857249,13394455,Individual_46,1/13/2010,,,Project_3,70,70,2,DOF_2,5,Feedlot_5(N=16),Feedlot_5,70,Pen_50190,5014535,2,NA,0,53,17,Late,2,50190,#N/A,10.1667,4.1667,6,7.1667,0,4.1667,0,0,0,3,0,0,3,YES,6,Medium total ADD exposure,Low total tetracycline exposure,Medium parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,Low parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE55,IE55,GCCACATA,Pool 1,,Pool 1,41,Individual - 2nd time point,Individual,2nd time point,148659,33338,33338,19797439,19232007,4728953,0.238866906,15068486,Individual_38,1/14/2010,,,Project_3,69,69,2,DOF_2,5,Feedlot_5(N=16),Feedlot_5,69,Pen_50190,5014736,1,NA,0,0,69,Metaphylaxis,2,50190,#N/A,7.1667,4.1667,3,7.1667,0,4.1667,0,0,0,0,0,0,3,YES,3,Low total ADD exposure,Low total tetracycline exposure,Medium parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE56,IE56,ACCACTGT,Pool 1,,Pool 1,42,Individual - 2nd time point,Individual,2nd time point,156905,34387,34387,24082109,23405466,5718438,0.237455864,18363671,Individual_39,1/14/2010,,,Project_3,69,69,2,DOF_2,5,Feedlot_5(N=16),Feedlot_5,69,Pen_50190,5014754,1,NA,0,0,69,Metaphylaxis,2,50190,#N/A,7.1667,4.1667,3,7.1667,0,4.1667,0,0,0,0,0,0,3,YES,3,Low total ADD exposure,Low total tetracycline exposure,Medium parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE57,IE57,AACTCACC,Pool 1,,Pool 1,43,Individual - 2nd time point,Individual,2nd time point,157634,49062,49057,18138331,17585483,3242674,0.178774662,14895657,Individual_40,1/14/2010,,,Project_3,70,70,2,DOF_2,5,Feedlot_5(N=16),Feedlot_5,70,Pen_50191,5014855,1,NA,0,0,70,Metaphylaxis,2,50191,#N/A,7.1667,4.1667,3,7.1667,0,4.1667,0,0,0,0,0,0,3,YES,3,Low total ADD exposure,Low total tetracycline exposure,Medium parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE58,IE58,GCTAACGA,Pool 1,,Pool 2,44,Individual - 2nd time point,Individual,2nd time point,142634,42598,42598,8782167,8504175,1962327,0.22344451,6819840,Individual_41,10/10/2009,,,Project_3,171,171,4,DOF_4,21,Feedlot_21(N=11),Feedlot_21,171,Pen_210366,21012773,1,NA,47,47,124,Early,4,210366,#N/A,11.0069,9.0069,2,10.9444,0.0625,8.9444,0.0625,0,0,0,0,0,2,YES,2,Medium total ADD exposure,Medium total tetracycline exposure,Low parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE59,IE59,CATCAAGT,Pool 3,,Pool 1,45,Individual - 2nd time point,Individual,2nd time point,154698,48224,48185,15375645,14820695,3665205,0.238377317,11710440,Individual_42,1/12/2010,,,Project_3,78,78,3,DOF_3,21,Feedlot_21(N=11),Feedlot_21,78,Pen_210424,21014504,1,NA,0,0,78,Metaphylaxis,3,210424,#N/A,7.1056,4.1056,3,7.0556,0.05,4.0556,0.05,0,0,0,0,0,3,YES,3,Low total ADD exposure,Low total tetracycline exposure,Medium parenteral tetracycline exposure,Low feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE6,IE6,AGAGTCAA,Pool 6,,Pool 1,46,Individual - 2nd time point,Individual,2nd time point,129039,38771,38743,0,0,0,NA,0,Individual_43,10/11/2009,,,Project_3,81,81,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,81,Pen_420117,42010882,2,NA,0,69,12,Late,3,420117,#N/A,23.5556,17.5556,6,17.5556,3,17.5556,0,0,3,3,0,0,0,YES,6,High total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,Low parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE62,IE62,AAGGTACA,Pool 3,,Pool 2,47,Individual - 2nd time point,Individual,2nd time point,155274,44864,44864,25239487,24531366,8124785,0.321907692,17114702,Individual_44,12/1/2009,Issue with not showing up on final exposure data,,Project_3,126,126,4,DOF_4,21,Feedlot_21(N=11),Feedlot_21,126,Pen_210416,21014055,0,NA,None,None,None,None,4,210416,NoTx,6.7417,6.7417,0,6.6667,0.075,6.6667,0.075,0,0,0,0,0,0,NO,0,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE63,IE63,CGCTGATC,Pool 3,,Pool 1,48,Individual - 2nd time point,Individual,2nd time point,141720,48541,48541,14628392,14207255,3541939,0.242127706,11086453,Individual_48,10/28/2009,,,Project_3,141,141,4,DOF_4,5,Feedlot_5(N=16),Feedlot_5,141,Pen_50176,5013665,1,NA,0,0,141,Metaphylaxis,4,50176,#N/A,18.8889,15.8889,3,15.8889,3,15.8889,0,0,3,0,0,0,0,YES,3,Medium total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE64,IE64,CCTAATCC,Pool 3,,Pool 1,49,Individual - 2nd time point,Individual,2nd time point,143225,37533,37533,19488355,18840488,5550330,0.284802386,13938025,Individual_49,1/13/2010,,,Project_3,70,70,2,DOF_2,5,Feedlot_5(N=16),Feedlot_5,70,Pen_50190,5014571,1,NA,0,0,70,Metaphylaxis,2,50190,#N/A,7.1667,4.1667,3,7.1667,0,4.1667,0,0,0,0,0,0,3,YES,3,Low total ADD exposure,Low total tetracycline exposure,Medium parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE65,IE65,CTGAGCCA,Pool 3,,Pool 2,50,Individual - 2nd time point,Individual,2nd time point,171377,61647,61647,16985106,15935624,3073356,0.180944175,13911750,Individual_50,31101240,,,Project_3,77,77,3,DOF_1,31,Feedlot_31(N=13),Feedlot_31,77,Pen_310214,31012391,1,NA,0,0,77,Metaphylaxis,1,310214,#N/A,6.2778,4.2778,2,6.2778,0,4.2778,0,0,0,0,0,0,2,YES,2,Low total ADD exposure,Low total tetracycline exposure,Low parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE66,IE66,AGCCATGC,Pool 3,,Pool 1,51,Individual - 2nd time point,Individual,2nd time point,148742,45584,45584,17682597,16739665,3462791,0.195830454,14219806,Individual_51,9/3/2009,,,Project_3,74,74,3,DOF_3,31,Feedlot_31(N=13),Feedlot_31,74,Pen_310218,31012598,1,NA,0,0,74,Metaphylaxis,3,310218,#N/A,6.1667,4.1667,2,6.1667,0,4.1667,0,0,0,0,0,0,2,YES,2,Low total ADD exposure,Low total tetracycline exposure,Low parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE68,IE68,GTACGCAA,Pool 3,,Pool 2,52,Individual - 2nd time point,Individual,2nd time point,148005,46819,46553,17933154,16890376,3222767,0.179709994,14710387,Individual_52,9/3/2009,,,Project_3,74,74,3,DOF_3,31,Feedlot_31(N=13),Feedlot_31,74,Pen_310218,31012556,1,NA,0,0,74,Metaphylaxis,3,310218,#N/A,6.1667,4.1667,2,6.1667,0,4.1667,0,0,0,0,0,0,2,YES,2,Low total ADD exposure,Low total tetracycline exposure,Low parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE69,IE69,AGTACAAG,Pool 3,,Pool 1,53,Individual - 2nd time point,Individual,2nd time point,146269,33207,32890,16221849,15522573,4034934,0.248734531,12186915,Individual_54,10/29/2009,,,Project_3,144,144,4,DOF_4,5,Feedlot_5(N=16),Feedlot_5,144,Pen_50178,5013889,1,NA,0,0,144,Metaphylaxis,4,50178,#N/A,19,16,3,16,3,16,0,0,3,0,0,0,0,YES,3,High total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE7,IE7,CCGACAAC,Pool 6,,Pool 1,54,Individual - 2nd time point,Individual,2nd time point,144425,39397,39274,0,0,0,NA,0,Individual_53,9/16/2009,,,Project_3,108,108,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,108,Pen_420105,42010065,2,NA,0,36,72,Late,3,420105,#N/A,12.0556,6.0556,6,9.0556,3,6.0556,0,0,3,0,0,0,3,YES,6,Medium total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE70,IE70,ACATTGGC,Pool 3,,Pool 2,55,Individual - 2nd time point,Individual,2nd time point,121105,31187,31079,15702305,14948510,3629689,0.231156445,12072616,Individual_55,10/8/2009,,,Project_3,133,133,4,DOF_4,21,Feedlot_21(N=11),Feedlot_21,133,Pen_210361,21012515,1,NA,0,0,133,Metaphylaxis,4,210361,#N/A,10.0444,7.0444,3,9.9444,0.1,6.9444,0.1,0,0,0,0,0,3,YES,3,Medium total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE71,IE71,ATTGAGGA,Pool 3,,Pool 1,56,Individual - 2nd time point,Individual,2nd time point,143137,43305,43305,15076613,14264924,3115874,0.206669363,11960739,Individual_56,1/14/2010,,,Project_3,70,70,2,DOF_2,5,Feedlot_5(N=16),Feedlot_5,70,Pen_50191,5014934,1,NA,0,0,70,Metaphylaxis,2,50191,#N/A,7.1667,4.1667,3,7.1667,0,4.1667,0,0,0,0,0,0,3,YES,3,Low total ADD exposure,Low total tetracycline exposure,Medium parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE73,IE73,GTCGTAGA,Pool 3,,Pool 1,57,Individual - 2nd time point,Individual,2nd time point,148566,40010,39898,16343714,15362903,3258677,0.199384118,13085037,Individual_57,8/26/2009,,,Project_3,78,78,3,DOF_3,31,Feedlot_31(N=13),Feedlot_31,78,Pen_310211,31012244,1,NA,0,0,78,Metaphylaxis,3,310211,#N/A,6.6667,4.6667,2,6.6667,0,4.6667,0,0,0,0,0,0,2,YES,2,Low total ADD exposure,Low total tetracycline exposure,Low parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE74,IE74,AGAGTCAA,Pool 3,,Pool 1,58,Individual - 2nd time point,Individual,2nd time point,130808,39904,39876,20214701,19083866,3846172,0.190266084,16368529,Individual_58,11/3/2009,Issue with not showing up on final exposure data,,Project_3,79,79,3,DOF_3,31,Feedlot_31(N=13),Feedlot_31,79,Pen_310263,31015354,2,NA,0,31,48,Late,3,310263,0,6.61474,4.6111,2.00364,6.6111,0.00364,4.6111,0,0,0.00364,0,0,0,2,YES,2.00364,Low total ADD exposure,Low total tetracycline exposure,Low parenteral tetracycline exposure,Low feed tetracycline exposure,Low total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE75,IE75,CCGACAAC,Pool 3,,Pool 2,59,Individual - 2nd time point,Individual,2nd time point,158269,49488,49426,15658022,14880889,3254024,0.207818331,12403998,Individual_59,8/26/2009,,,Project_3,92,92,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,92,Pen_420093,42009541,1,NA,0,0,92,Metaphylaxis,3,420093,#N/A,10.2778,8.2778,2,10.2778,0,8.2778,0,0,0,0,0,0,2,YES,2,Medium total ADD exposure,Medium total tetracycline exposure,Low parenteral tetracycline exposure,Medium feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
IE77,IE77,ACGTATCA,Pool 3,,Pool 1,60,Individual - 2nd time point,Individual,2nd time point,147345,38690,38584,17295179,16352131,3742952,0.216415916,13552227,Individual_60,10/28/2009,,,Project_3,90,90,3,DOF_3,42,Feedlot_42(N=20),Feedlot_42,90,Pen_420123,42012115,1,NA,0,0,90,Metaphylaxis,3,420123,#N/A,18.0556,15.0556,3,15.0556,3,15.0556,0,0,3,0,0,0,0,YES,3,Medium total ADD exposure,High total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA1,PA1,GGAGAACA,Pool 6,,Pool 6,1,Pen - 1st time point,Pen,1st time point,205416,64523,64523,19245266,18651664,593602,0.0308,15301366,Pen_1,P210319,P210319|08-19-2009,8/19/2009,Project_4,6,6,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,89,Pen_210319,P210319 2009-08-19,51,120,1,113,,,NA,NA,,8.333333333,8.333333333,0,8.333333333,0,8.333333333,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA10,PA10,ACGTATCA,Pool 4,,Pool 6,2,Pen - 1st time point,Pen,1st time point,200658,58042,58042,16313306,15760896,552410,0.0339,13814837,Pen_7,P210335,P210335|09-10-2009,9/10/2009,Project_4,2,2,1,DOF_1,21,Feedlot_21(N=24),Feedlot_21,112,Pen_210335,P210335 2009-09-10,40,NA,1,110,,,NA,NA,,5,5,0,5,0,5,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA12,PA12,CTAAGGTC,Pool 4,,Pool 6,3,Pen - 1st time point,Pen,1st time point,202240,63877,63840,22845224,22021720,823504,0.036,19366885,Pen_8,P210340,P210340|09-10-2009,9/10/2009,Project_4,1,1,1,DOF_1,21,Feedlot_21(N=24),Feedlot_21,140,Pen_210340,P210340 2009-09-10,36,222,1,220,,,NA,NA,,2,0,2,0,0,0,0,0,0,0,2,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,Low parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA13,PA13,CGACACAC,Pool 4,,Pool 6,4,Pen - 1st time point,Pen,1st time point,211817,43185,43181,20358235,19667403,690832,0.0339,16756102,Pen_9,P210344,P210344|09-15-2009,9/15/2009,Project_4,0,0,1,DOF_1,21,Feedlot_21(N=24),Feedlot_21,105,Pen_210344,P210344 2009-09-15,92,NA,-1,106,,,NA,NA,,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA14,PA14,CCGTGAGA,Pool 4,,Pool 6,5,Pen - 1st time point,Pen,1st time point,203311,43525,43490,18127401,17746083,381318,0.021,12512431,Pen_10,P310229,P310229|09-17-2009,9/17/2009,Project_4,0,0,1,DOF_1,31,Feedlot_31(N=9),Feedlot_31,68,Pen_310229,P310229 2009-09-17,26,NA,13,68,,,NA,NA,,109.0555556,109.0555556,0,109.0555556,0,109.0555556,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA15,PA15,GTGTTCTA,Pool 4,,Pool 6,6,Pen - 1st time point,Pen,1st time point,203727,64735,64735,16724173,16198353,525820,0.0314,13667444,Pen_11,P310230,P310230|09-18-2009,9/18/2009,Project_4,0,0,1,DOF_1,31,Feedlot_31(N=9),Feedlot_31,67,Pen_310230,P310230 2009-09-18,15,NA,1,67,,,NA,NA,,8.388888889,8.388888889,0,8.388888889,0,8.388888889,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA16,PA16,AGATCGCA,Pool 1,,Pool 6,7,Pen - 1st time point,Pen,1st time point,201041,44562,44550,17983263,17478550,504713,0.0281,14431565,Pen_12,P310233,P310233|09-23-2009,9/23/2009,Project_4,0,0,1,DOF_1,31,Feedlot_31(N=9),Feedlot_31,69,Pen_310233,P310233 2009-09-23,53,NA,1,69,,,NA,NA,,11.27777778,11.27777778,0,11.27777778,0,11.27777778,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA17,PA17,CAATGGAA,Pool 4,,Pool 6,8,Pen - 1st time point,Pen,1st time point,203366,48937,48937,17306645,16676010,630635,0.0364,14197948,Pen_13,P210350,P210350|10-02-2009,10/2/2009,Project_4,10,10,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,127,Pen_210350,P210350 2009-10-02,136,177,10,167,,,NA,NA,,933.5,96.5,837,96.5,0,96.5,0,0,0,0,837,0,0,,NA,Medium total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,High parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA18,PA18,AAGAGATC,Pool 1,,Pool 6,9,Pen - 1st time point,Pen,1st time point,203702,53561,53535,14501953,14287626,214327,0.0148,7538196,Pen_14,P420117,P420117|10-13-2009,10/13/2009,Project_4,3,3,1,DOF_1,42,Feedlot_42(N=6),Feedlot_42,97,Pen_420117,P420117 2009-10-13,297,NA,3,94,,,NA,NA,,1935.333333,1279.333333,656,1279.333333,0,1279.333333,0,0,0,0,656,0,0,,NA,High total ADD exposure,Medium total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,High parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA19,PA19,CAACCACA,Pool 1,,Pool 6,10,Pen - 1st time point,Pen,1st time point,94433,25997,25997,16832557,16319831,512726,0.0305,12790790,Pen_15,P210359,P210359|10-22-2009,10/22/2009,Project_4,16,16,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,106,Pen_210359,P210359 2009-10-22,21,125,16,90,,,NA,NA,,64.88888889,64.88888889,0,64.88888889,0,64.88888889,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA2,PA2,AGTACAAG,Pool 4,,Pool 6,11,Pen - 1st time point,Pen,1st time point,209136,57305,57305,15899902,15353785,546117,0.0343,12772461,Pen_2,P310211,P310211|08-27-2009,8/27/2009,Project_4,7,7,2,DOF_2,31,Feedlot_31(N=9),Feedlot_31,84,Pen_310211,P310211 2009-08-27,75,NA,7,77,,,NA,NA,,431.4444444,75.44444444,356,431.4444444,0,75.44444444,0,0,0,0,0,0,356,,NA,Medium total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA20,PA20,TGGAACAA,Pool 1,,Pool 6,12,Pen - 1st time point,Pen,1st time point,217455,49004,48987,16220163,15688409,531754,0.0328,12791456,Pen_16,P210360,P210360|10-22-2009,10/22/2009,Project_4,14,14,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,141,Pen_210360,P210360 2009-10-22,151,215,14,201,,,NA,NA,,748.9611111,144.9611111,604,703.1111111,4.85,140.1111111,4.85,0,0,0,41,0,563,,NA,Medium total ADD exposure,Medium total tetracycline exposure,High parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA21,PA21,CCTCTATC,Pool 1,,Pool 6,13,Pen - 1st time point,Pen,1st time point,195208,48435,48405,16806805,16293042,513763,0.0306,13199518,Pen_17,P210361,P210361|10-22-2009,10/22/2009,Project_4,14,14,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,141,Pen_210361,P210361 2009-10-22,72,196,14,181,,,NA,NA,,385.4694444,75.46944444,310,379.9444444,2.525,72.94444444,2.525,0,0,0,3,0,307,,NA,Low total ADD exposure,Low total tetracycline exposure,Medium parenteral tetracycline exposure,Low feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,Low parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA23,PA23,ACAGATTC,Pool 1,,Pool 6,14,Pen - 1st time point,Pen,1st time point,207462,52298,52298,18113698,17597626,516072,0.0285,13690578,Pen_18,P210362,P210362|10-22-2009,10/22/2009,Project_4,14,14,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,141,Pen_210362,P210362 2009-10-22,80,207,14,192,,,NA,NA,,464.6555556,92.65555556,372,452.5555556,3.1,89.55555556,3.1,0,0,0,9,0,363,,NA,Medium total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Low feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,Low parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA24,PA24,CCAGTTCA,Pool 1,,Pool 6,15,Pen - 1st time point,Pen,1st time point,124651,33303,33303,17358216,16856228,501988,0.0289,13578098,Pen_19,P050175,P050175|10-27-2009,10/27/2009,Project_4,2,2,1,DOF_1,5,Feedlot_5(N=5),Feedlot_5,65,Pen_50175,P050175 2009-10-27,12,NA,2,63,,,NA,NA,,7.666666667,7.666666667,0,7.666666667,0,7.666666667,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA25,PA25,TGGCTTCA,Pool 1,,Pool 6,16,Pen - 1st time point,Pen,1st time point,214124,51944,51841,8739016,8480382,258634,0.0296,6457159,Pen_20,P310262,P310262|10-30-2009,10/30/2009,Project_4,0,0,1,DOF_1,31,Feedlot_31(N=9),Feedlot_31,83,Pen_310262,P310262 2009-10-30,50,94,2,94,,,NA,NA,,20.11111111,20.11111111,0,20.11111111,0,20.11111111,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA26,PA26,CGACTGGA,Pool 1,,Pool 6,17,Pen - 1st time point,Pen,1st time point,205724,45251,45251,14393063,13950807,442256,0.0307,11609336,Pen_21,P310263,P310263|10-30-2009,10/30/2009,Project_4,0,0,1,DOF_1,31,Feedlot_31(N=9),Feedlot_31,83,Pen_310263,P310263 2009-10-30,90,117,0,117,,,NA,NA,,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA27,PA27,AGCACCTC,Pool 4,,Pool 6,18,Pen - 1st time point,Pen,1st time point,143915,36997,36986,18623839,18043040,580799,0.0312,15009155,Pen_22,P420118,P420118|10-30-2009,10/30/2009,Project_4,15,15,2,DOF_2,42,Feedlot_42(N=6),Feedlot_42,92,Pen_420118,P420118 2009-10-30,296,NA,15,77,,,NA,NA,,3950.5,2726.5,1224,2728.5,0,2726.5,0,0,0,16,1203,3,2,,NA,High total ADD exposure,High total tetracycline exposure,Low parenteral tetracycline exposure,High feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,High parenteral phenicol exposure,High parenteral fluoroquinolones exposure,Low parenteral sulfonamide exposure
PA28,PA28,CAGCGTTA,Pool 4,,Pool 6,19,Pen - 1st time point,Pen,1st time point,219411,47830,47820,23948621,23160374,788247,0.0329,19083684,Pen_23,P420119,P420119|10-30-2009,10/30/2009,Project_4,15,15,2,DOF_2,42,Feedlot_42(N=6),Feedlot_42,92,Pen_420119,P420119 2009-10-30,268,NA,15,77,,,NA,NA,,4292,3102,1190,3104,0,3102,0,0,0,0,1188,0,2,,NA,High total ADD exposure,High total tetracycline exposure,Low parenteral tetracycline exposure,High feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,High parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA29,PA29,TTCACGCA,Pool 1,,Pool 6,20,Pen - 1st time point,Pen,1st time point,205143,44340,44329,17465674,16820291,645383,0.037,15366170,Pen_24,P420123,P420123|10-30-2009,10/30/2009,Project_4,3,3,1,DOF_1,42,Feedlot_42(N=6),Feedlot_42,107,Pen_420123,P420123 2009-10-30,288,NA,3,104,,,NA,NA,,2259.833333,1269.833333,990,1269.833333,0,1269.833333,0,0,0,0,990,0,0,,NA,High total ADD exposure,Medium total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,High parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA30,PA30,TAGGATGA,Pool 4,,Pool 6,21,Pen - 1st time point,Pen,1st time point,217501,48811,48801,18184183,17532858,651325,0.0358,14867478,Pen_25,P210379,P210379|11-03-2009,11/3/2009,Project_4,11,11,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,144,Pen_210379,P210379 2009-11-03,112,200,11,189,,,NA,NA,,612,95,517,593,0,95,0,0,0,0,19,0,498,,NA,Medium total ADD exposure,Medium total tetracycline exposure,High parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA31,PA31,CAAGACTA,Pool 1,,Pool 6,22,Pen - 1st time point,Pen,1st time point,219078,49514,49505,19729423,19133441,595982,0.0302,15377932,Pen_26,P210380,P210380|11-04-2009,11/4/2009,Project_4,8,8,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,142,Pen_210380,P210380 2009-11-04,46,NA,8,134,,,NA,NA,,40.66666667,34.66666667,6,36.66666667,0,34.66666667,0,0,0,0,4,0,2,,NA,Low total ADD exposure,Low total tetracycline exposure,Low parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,Low parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA32,PA32,CCTCCTGA,Pool 4,,Pool 6,23,Pen - 1st time point,Pen,1st time point,210605,45963,45963,19838299,19220111,618188,0.0312,15468515,Pen_27,P210381,P210381|11-04-2009,11/4/2009,Project_4,8,8,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,142,Pen_210381,P210381 2009-11-04,40,202,8,193,,,NA,NA,,35,32,3,32,0,32,0,0,0,0,3,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,Low parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA33,PA33,TGGTGGTA,Pool 1,,Pool 6,24,Pen - 1st time point,Pen,1st time point,206024,42699,42699,17747396,17181742,565654,0.0319,14062422,Pen_28,P210389,P210389|11-10-2009,11/10/2009,Project_4,5,5,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,133,Pen_210389,P210389 2009-11-10,22,NA,5,128,,,NA,NA,,141.2222222,12.22222222,129,138.2222222,0,12.22222222,0,0,0,0,3,0,126,,NA,Low total ADD exposure,Low total tetracycline exposure,Medium parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,Low parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA35,PA35,AGTGGTCA,Pool 4,,Pool 6,25,Pen - 1st time point,Pen,1st time point,202773,56452,56431,22449389,21653457,795932,0.0355,18693435,Pen_29,P210401,P210401|12-02-2009,12/2/2009,Project_4,13,13,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,140,Pen_210401,P210401 2009-12-02,51,179,13,166,,,NA,NA,,114.9444444,98.94444444,16,98.94444444,0,98.94444444,0,0,0,0,16,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA36,PA36,CACCTTAC,Pool 1,,Pool 6,26,Pen - 1st time point,Pen,1st time point,205887,37837,37819,11782368,11362164,420204,0.0357,9986330,Pen_30,P210397,P210397|12-10-2009,12/10/2009,Project_4,27,27,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,132,Pen_210397,P210397 2009-12-10,32,NA,28,105,,,NA,NA,,118.2166667,97.21666667,21,88.66666667,11.55,88.66666667,8.55,0,3,0,18,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,Medium feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA37,PA37,AGTGGTCA,Pool 2,,Pool 6,27,Pen - 1st time point,Pen,1st time point,205783,47474,47474,23922521,21946697,1975824,0.0826,20074384,Pen_31,P210399,P210399|12-10-2009,12/10/2009,Project_4,28,28,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,133,Pen_210399,P210399 2009-12-10,103,186,28,158,,,NA,NA,,265.8708333,136.8708333,129,168.8333333,18.0375,124.8333333,12.0375,1,6,0,54,24,44,,NA,Low total ADD exposure,Low total tetracycline exposure,Low parenteral tetracycline exposure,Medium feed tetracycline exposure,High total MLS exposure,Medium parenteral MLS exposure,Medium feed MLS exposure,Low parenteral betalactams exposure,No parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,High parenteral sulfonamide exposure
PA38,PA38,ACAGCAGA,Pool 4,,Pool 6,28,Pen - 1st time point,Pen,1st time point,201088,51123,51123,18012793,17301264,711529,0.0395,15185345,Pen_32,P210417,P210417|12-11-2009,12/11/2009,Project_4,9,9,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,127,Pen_210417,P210417 2009-12-11,67,166,9,157,,,NA,NA,,382.3333333,49.33333333,333,49.33333333,0,49.33333333,0,0,0,0,333,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,High parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA39,PA39,AAGACGGA,Pool 1,,Pool 6,29,Pen - 1st time point,Pen,1st time point,201971,44042,44024,16101974,15339151,762823,0.0474,13328998,Pen_33,P210418,P210418|12-11-2009,12/11/2009,Project_4,8,8,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,126,Pen_210418,P210418 2009-12-11,64,165,8,157,,,NA,NA,,272.1111111,35.11111111,237,35.11111111,0,35.11111111,0,0,0,0,237,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,High parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA4,PA4,ACATTGGC,Pool 4,,Pool 6,30,Pen - 1st time point,Pen,1st time point,145111,44552,44508,19966059,19279943,686116,0.0344,19255721,Pen_3,P210321,P210321|09-01-2009,9/1/2009,Project_4,7,7,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,77,Pen_210321,P210321 2009-09-01,9,NA,8,70,,,NA,NA,,33.77777778,33.77777778,0,33.77777778,0,33.77777778,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA40,PA40,ACAGCAGA,Pool 1,,Pool 6,31,Pen - 1st time point,Pen,1st time point,190351,34962,34824,16032844,15434962,597882,0.0373,13814307,Pen_34,P210422,P210422|12-11-2009,12/11/2009,Project_4,2,2,1,DOF_1,21,Feedlot_21(N=24),Feedlot_21,132,Pen_210422,P210422 2009-12-11,94,159,2,157,,,NA,NA,,473.8888889,17.88888889,456,17.88888889,0,17.88888889,0,0,0,0,456,0,0,,NA,Medium total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,High parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA41,PA41,CATACCAA,Pool 1,,Pool 6,32,Pen - 1st time point,Pen,1st time point,204697,62960,62939,14235347,13735024,500323,0.0351,11945711,Pen_35,L310315,L310315|01-13-2010,1/13/2010,Project_4,0,0,1,DOF_1,31,Feedlot_31(N=9),Feedlot_31,69,Pen_310315,L310315 2010-01-13,79,124,1,124,,,NA,NA,,10,10,0,10,0,10,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA42,PA42,ACACAGAA,Pool 1,,Pool 6,33,Pen - 1st time point,Pen,1st time point,204651,37223,37199,13237750,12830726,407024,0.0307,10298019,Pen_36,P050189,P050189|01-13-2010,1/13/2010,Project_4,6,6,2,DOF_2,5,Feedlot_5(N=5),Feedlot_5,74,Pen_50189,P050189 2010-01-13,100,NA,6,68,,,NA,NA,,1140.333333,92.33333333,1048,1140.333333,0,92.33333333,0,0,0,0,0,0,1048,,NA,High total ADD exposure,Medium total tetracycline exposure,High parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA43,PA43,TATCAGCA,Pool 4,,Pool 6,34,Pen - 1st time point,Pen,1st time point,204198,41821,41821,16540288,15978582,561706,0.034,13582257,Pen_37,L310316,L310316|01-14-2010,1/14/2010,Project_4,0,0,1,DOF_1,31,Feedlot_31(N=9),Feedlot_31,64,Pen_310316,L310316 2010-01-14,60,88,1,88,,,NA,NA,,20,20,0,20,0,20,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA45,PA45,TATCAGCA,Pool 1,,Pool 6,35,Pen - 1st time point,Pen,1st time point,211854,40277,40271,12191687,11719668,472019,0.0387,11062610,Pen_38,P050191,P050191|01-15-2010,1/15/2010,Project_4,1,1,1,DOF_1,5,Feedlot_5(N=5),Feedlot_5,68,Pen_50191,P050191 2010-01-15,96,NA,8,67,,,NA,NA,,440,132,308,440,0,132,0,0,0,0,0,0,308,,NA,Medium total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA46,PA46,AACAACCA,Pool 1,,Pool 6,36,Pen - 1st time point,Pen,1st time point,115191,25441,25435,18517044,17969098,547946,0.0296,13992825,Pen_39,P420126,P420126|01-15-2010,1/15/2010,Project_4,68,68,2,DOF_2,42,Feedlot_42(N=6),Feedlot_42,95,Pen_420126,P420126 2010-01-15,255,NA,68,27,,,NA,NA,,8401.555556,7075.555556,1326,7132.555556,12,7075.555556,0,24,12,3,1203,27,57,,NA,High total ADD exposure,High total tetracycline exposure,Low parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,High parenteral MLS exposure,No feed MLS exposure,High parenteral betalactams exposure,Low parenteral phenicol exposure,High parenteral fluoroquinolones exposure,High parenteral sulfonamide exposure
PA47,PA47,AATCCGTC,Pool 1,,Pool 6,37,Pen - 1st time point,Pen,1st time point,202969,34288,34281,17649709,17129723,519986,0.0295,13656803,Pen_40,P420128,P420128|01-15-2010,1/15/2010,Project_4,59,59,2,DOF_2,42,Feedlot_42(N=6),Feedlot_42,86,Pen_420128,P420128 2010-01-15,270,NA,59,27,,,NA,NA,,9469.5,8212.5,1257,8230.5,0,8212.5,0,15,0,0,1218,6,18,,NA,High total ADD exposure,High total tetracycline exposure,Low parenteral tetracycline exposure,High feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,Medium parenteral betalactams exposure,No parenteral phenicol exposure,High parenteral fluoroquinolones exposure,Medium parenteral sulfonamide exposure
PA48,PA48,GAACAGGC,Pool 1,,Pool 6,38,Pen - 1st time point,Pen,1st time point,212282,42536,42536,11188433,10835821,352612,0.0315,9015425,Pen_41,P210424,P210424|01-18-2010,1/18/2010,Project_4,6,6,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,79,Pen_210424,P210424 2010-01-18,68,125,6,119,,,NA,NA,,466.1666667,39.16666667,427,466.1666667,0,39.16666667,0,0,0,0,0,0,427,,NA,Medium total ADD exposure,Medium total tetracycline exposure,High parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA49,PA49,CAAGGAGC,Pool 1,,Pool 6,39,Pen - 1st time point,Pen,1st time point,214693,53228,53224,13878286,13461832,416454,0.03,10722889,Pen_42,P210323,P210323|09-01-2009,9/1/2009,Project_4,7,7,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,77,Pen_210323,P210323 2009-09-01,11,NA,4,70,,,NA,NA,,15.33333333,15.33333333,0,15.33333333,0,15.33333333,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA50,PA50,ATAGCGAC,Pool 1,,Pool 6,40,Pen - 1st time point,Pen,1st time point,148209,33657,33641,14745894,14301601,444293,0.0301,12164921,Pen_43,P050168,P050168|10-12-2009,10/12/2009,Project_4,3,3,1,DOF_1,5,Feedlot_5(N=5),Feedlot_5,81,Pen_50168,P050168 2009-10-12,42,NA,2,78,,,NA,NA,,16.77777778,16.77777778,0,16.77777778,0,16.77777778,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA7,PA7,ATTGAGGA,Pool 4,,Pool 6,41,Pen - 1st time point,Pen,1st time point,208792,63902,63902,18534507,17872030,662477,0.0357,15571947,Pen_4,P310218,P310218|09-05-2009,9/5/2009,Project_4,2,2,1,DOF_1,31,Feedlot_31(N=9),Feedlot_31,74,Pen_310218,P310218 2009-09-05,86,138,3,136,,,NA,NA,,708.3333333,28.33333333,680,708.3333333,0,28.33333333,0,0,0,0,0,0,680,,NA,Medium total ADD exposure,Medium total tetracycline exposure,High parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA8,PA8,GTCGTAGA,Pool 2,,Pool 6,42,Pen - 1st time point,Pen,1st time point,200763,68276,68268,20241599,19392152,849447,0.042,15731211,Pen_5,P050156,P050156|09-10-2009,9/10/2009,Project_4,0,0,1,DOF_1,5,Feedlot_5(N=5),Feedlot_5,75,Pen_50156,P050156 2009-09-10,78,NA,0,75,,,NA,NA,,0,0,0,0,0,0,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PA9,PA9,CCGACAAC,Pool 4,,Pool 6,43,Pen - 1st time point,Pen,1st time point,212354,60190,60190,14877763,14364088,513675,0.0345,12445433,Pen_6,P210326,P210326|09-10-2009,9/10/2009,Project_4,7,7,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,68,Pen_210326,P210326 2009-09-10,33,99,7,61,,,NA,NA,,38.11111111,38.11111111,0,38.11111111,0,38.11111111,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE10,PE10,ATTGGCTC,Pool 4,,Pool 6,1,Pen - 2nd time point,Pen,2nd time point,166623,58715,58715,18605546,18051388,554158,0.0298,14886059,Pen_10,P310229,P310229|11-24-2009,11/24/2009,Project_4,68,68,2,DOF_2,31,Feedlot_31(N=9),Feedlot_31,68,Pen_310229,P310229 2009-11-24,26,NA,81,0,,,NA,NA,,694.5,679.5,15,681.5,0,679.5,0,10,0,0,3,0,2,,NA,Medium total ADD exposure,Medium total tetracycline exposure,Low parenteral tetracycline exposure,Medium feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,Medium parenteral betalactams exposure,No parenteral phenicol exposure,Low parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE11,PE11,GATGAATC,Pool 4,,Pool 6,2,Pen - 2nd time point,Pen,2nd time point,207772,66243,66243,17383250,16854961,528289,0.0304,14178240,Pen_11,P310230,P310230|11-24-2009,11/24/2009,Project_4,67,67,2,DOF_2,31,Feedlot_31(N=9),Feedlot_31,67,Pen_310230,P310230 2009-11-24,15,NA,68,0,,,NA,NA,,570.4444444,570.4444444,0,570.4444444,0,570.4444444,0,0,0,0,0,0,0,,NA,Medium total ADD exposure,Medium total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE12,PE12,AGCAGGAA,Pool 4,,Pool 6,3,Pen - 2nd time point,Pen,2nd time point,211395,79485,79485,13215632,12766475,449157,0.034,10594776,Pen_12,P310233,P310233|12-01-2009,12/1/2009,Project_4,69,69,2,DOF_2,31,Feedlot_31(N=9),Feedlot_31,69,Pen_310233,P310233 2009-12-01,53,NA,70,0,,,NA,NA,,859.4917172,789.4444444,70.04727273,825.4444444,0,789.4444444,0,1,0,0,18.04727273,15,36,,NA,Medium total ADD exposure,Medium total tetracycline exposure,Low parenteral tetracycline exposure,Medium feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,Low parenteral betalactams exposure,No parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,High parenteral sulfonamide exposure
PE13,PE13,GAGCTGAA,Pool 4,,Pool 6,4,Pen - 2nd time point,Pen,2nd time point,200454,59544,59544,14794685,14356244,438441,0.0296,11486682,Pen_7,P210335,P210335|12-29-2009,12/29/2009,Project_4,112,112,3,DOF_3,21,Feedlot_21(N=24),Feedlot_21,112,Pen_210335,P210335 2009-12-29,40,NA,111,0,,,NA,NA,,506.875,506.875,0,490,16.875,490,16.875,0,0,0,0,0,0,,NA,Medium total ADD exposure,Medium total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,High total MLS exposure,No parenteral MLS exposure,High feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE14,PE14,GAGTTAGC,Pool 4,,Pool 6,5,Pen - 2nd time point,Pen,2nd time point,211609,61091,61083,12709289,12337805,371484,0.0292,9788139,Pen_44,P210336,P210336|12-29-2009,12/29/2009,Project_4,112,112,3,DOF_3,21,Feedlot_21(N=24),Feedlot_21,112,Pen_210336,P210336 2009-12-29,72,NA,111,0,,,NA,NA,,1002.486111,1002.486111,0,969.1111111,33.375,969.1111111,33.375,0,0,0,0,0,0,,NA,Medium total ADD exposure,Medium total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,High total MLS exposure,No parenteral MLS exposure,High feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE15,PE15,CGAACTTA,Pool 4,,Pool 6,6,Pen - 2nd time point,Pen,2nd time point,201707,50831,50828,14725154,14285630,439524,0.0298,11324962,Pen_9,P210344,P210344|12-29-2009,12/29/2009,Project_4,105,105,3,DOF_3,21,Feedlot_21(N=24),Feedlot_21,105,Pen_210344,P210344 2009-12-29,92,NA,104,1,,,NA,NA,,1045.8,1024.8,21,1008.5,21.3,1006.5,18.3,10,3,0,3,3,2,,NA,Medium total ADD exposure,Medium total tetracycline exposure,Low parenteral tetracycline exposure,High feed tetracycline exposure,High total MLS exposure,Low parenteral MLS exposure,High feed MLS exposure,Medium parenteral betalactams exposure,No parenteral phenicol exposure,Low parenteral fluoroquinolones exposure,Low parenteral sulfonamide exposure
PE16,PE16,ACGCTCGA,Pool 1,,Pool 6,7,Pen - 2nd time point,Pen,2nd time point,202647,50785,50748,10966566,10570501,396065,0.0361,9133328,Pen_19,P050175,P050175|12-29-2009,12/29/2009,Project_4,65,65,2,DOF_2,5,Feedlot_5(N=5),Feedlot_5,65,Pen_50175,P050175 2009-12-29,12,NA,65,0,,,NA,NA,,261.1666667,249.1666667,12,258.1666667,0,249.1666667,0,0,0,0,3,0,9,,NA,Low total ADD exposure,Low total tetracycline exposure,Low parenteral tetracycline exposure,Medium feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,Low parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE17,PE17,CTCAATGA,Pool 1,,Pool 6,8,Pen - 2nd time point,Pen,2nd time point,203761,43359,43341,11529527,11079686,449841,0.039,9444897,Pen_14,P420117,P420117|01-15-2010,1/15/2010,Project_4,97,97,3,DOF_3,42,Feedlot_42(N=6),Feedlot_42,97,Pen_420117,P420117 2010-01-15,297,NA,97,0,,,NA,NA,,10008.11111,8641.111111,1367,8687.111111,9,8641.111111,0,20,9,27,1251,14,46,,NA,High total ADD exposure,High total tetracycline exposure,Low parenteral tetracycline exposure,High feed tetracycline exposure,Low total MLS exposure,Medium parenteral MLS exposure,No feed MLS exposure,High parenteral betalactams exposure,High parenteral phenicol exposure,High parenteral fluoroquinolones exposure,Medium parenteral sulfonamide exposure
PE18,PE18,TCCGTCTA,Pool 1,,Pool 6,9,Pen - 2nd time point,Pen,2nd time point,204018,49260,49231,13209126,12765325,443801,0.0336,10733743,Pen_22,P420118,P420118|01-15-2010,1/15/2010,Project_4,92,92,3,DOF_3,42,Feedlot_42(N=6),Feedlot_42,92,Pen_420118,P420118 2010-01-15,296,NA,92,0,,,NA,NA,,10113.33333,8822.333333,1291,8858.333333,6,8822.333333,0,3,6,24,1212,10,36,,NA,High total ADD exposure,High total tetracycline exposure,Low parenteral tetracycline exposure,High feed tetracycline exposure,Low total MLS exposure,Medium parenteral MLS exposure,No feed MLS exposure,Low parenteral betalactams exposure,High parenteral phenicol exposure,High parenteral fluoroquinolones exposure,Medium parenteral sulfonamide exposure
PE19,PE19,GCTCGGTA,Pool 4,,Pool 6,10,Pen - 2nd time point,Pen,2nd time point,197577,55147,55141,18008957,17531127,477830,0.0265,13419833,Pen_23,P420119,P420119|01-15-2010,1/15/2010,Project_4,92,92,3,DOF_3,42,Feedlot_42(N=6),Feedlot_42,92,Pen_420119,P420119 2010-01-15,268,NA,92,0,,,NA,NA,,8480,7172,1308,7210,9,7172,0,16,9,15,1212,18,38,,NA,High total ADD exposure,High total tetracycline exposure,Low parenteral tetracycline exposure,High feed tetracycline exposure,Low total MLS exposure,Medium parenteral MLS exposure,No feed MLS exposure,High parenteral betalactams exposure,Medium parenteral phenicol exposure,High parenteral fluoroquinolones exposure,High parenteral sulfonamide exposure
PE2,PE2,CATCAAGT,Pool 6,,Pool 6,11,Pen - 2nd time point,Pen,2nd time point,215523,39327,39266,19594710,18833188,761522,0.0389,15553194,Pen_1,P210319,P210319|11-10-2009,11/10/2009,Project_4,89,89,3,DOF_3,21,Feedlot_21(N=24),Feedlot_21,89,Pen_210319,P210319 2009-11-10,51,120,84,30,,,NA,NA,,703.875,701.875,2,702,1.875,700,1.875,0,0,0,0,0,2,,NA,Medium total ADD exposure,Medium total tetracycline exposure,Low parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE21,PE21,ACACGACC,Pool 4,,Pool 6,12,Pen - 2nd time point,Pen,2nd time point,212627,47451,47451,13410196,13001729,408467,0.0305,12964737,Pen_15,P210359,P210359|01-20-2010,1/20/2010,Project_4,106,106,3,DOF_3,21,Feedlot_21(N=24),Feedlot_21,106,Pen_210359,P210359 2010-01-20,21,125,106,0,,,NA,NA,,419.1416667,419.1416667,0,413.6666667,5.475,413.6666667,5.475,0,0,0,0,0,0,,NA,Medium total ADD exposure,Medium total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE22,PE22,AGTCACTA,Pool 4,,Pool 6,13,Pen - 2nd time point,Pen,2nd time point,219091,53854,53854,22258086,21526806,731280,0.0329,17668967,Pen_20,P310262,P310262|01-21-2010,1/21/2010,Project_4,83,83,3,DOF_3,31,Feedlot_31(N=9),Feedlot_31,83,Pen_310262,P310262 2010-01-21,50,94,85,11,,,NA,NA,,1235.722222,854.7222222,381,1218.722222,0,854.7222222,0,0,0,3,0,14,364,,NA,High total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,Low parenteral phenicol exposure,No parenteral fluoroquinolones exposure,Medium parenteral sulfonamide exposure
PE23,PE23,AACGCTTA,Pool 2,,Pool 6,14,Pen - 2nd time point,Pen,2nd time point,215521,55032,55032,21363130,20623950,739180,0.0346,16480020,Pen_21,P310263,P310263|01-21-2010,1/21/2010,Project_4,83,83,3,DOF_3,31,Feedlot_31(N=9),Feedlot_31,83,Pen_310263,P310263 2010-01-21,90,117,83,34,,,NA,NA,,1192.126465,811.5555556,380.5709091,1173.555556,0,811.5555556,0,3,0,0,9.570909091,6,362,,NA,High total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,Low parenteral betalactams exposure,No parenteral phenicol exposure,Low parenteral fluoroquinolones exposure,Medium parenteral sulfonamide exposure
PE25,PE25,GGAGAACA,Pool 4,,Pool 6,15,Pen - 2nd time point,Pen,2nd time point,103458,27701,27701,10303962,9996162,307800,0.0299,7850465,Pen_8,P210340,P210340|01-27-2010,1/27/2010,Project_4,140,140,4,DOF_4,21,Feedlot_21(N=24),Feedlot_21,140,Pen_210340,P210340 2010-01-27,36,222,140,81,,,NA,NA,,715.0652778,712.0652778,3,707.7777778,4.2875,707.7777778,4.2875,0,0,0,3,0,0,,NA,Medium total ADD exposure,Medium total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,Low parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE26,PE26,AGGCTAAC,Pool 1,,Pool 6,16,Pen - 2nd time point,Pen,2nd time point,206272,47325,47325,11578677,11158964,419713,0.0362,9560227,Pen_13,P210350,P210350|01-27-2010,1/27/2010,Project_4,127,127,4,DOF_4,21,Feedlot_21(N=24),Feedlot_21,127,Pen_210350,P210350 2010-01-27,136,177,127,50,,,NA,NA,,1997.895833,1330.895833,667,1366.833333,21.0625,1318.833333,12.0625,7,9,18,582,3,48,,NA,High total ADD exposure,Medium total tetracycline exposure,Low parenteral tetracycline exposure,High feed tetracycline exposure,High total MLS exposure,Medium parenteral MLS exposure,Medium feed MLS exposure,Medium parenteral betalactams exposure,High parenteral phenicol exposure,High parenteral fluoroquinolones exposure,Low parenteral sulfonamide exposure
PE27,PE27,AACCGAGA,Pool 1,,Pool 6,17,Pen - 2nd time point,Pen,2nd time point,183469,46817,46814,13006223,12504874,501349,0.0385,10915575,Pen_24,P420123,P420123|02-11-2010,2/11/2010,Project_4,107,107,3,DOF_3,42,Feedlot_42(N=6),Feedlot_42,107,Pen_420123,P420123 2010-02-11,288,NA,107,0,,,NA,NA,,8915.722222,7596.722222,1319,7643.722222,12,7596.722222,0,23,12,6,1215,16,47,,NA,High total ADD exposure,High total tetracycline exposure,Low parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,High parenteral MLS exposure,No feed MLS exposure,High parenteral betalactams exposure,Medium parenteral phenicol exposure,High parenteral fluoroquinolones exposure,High parenteral sulfonamide exposure
PE28,PE28,ACAAGCTA,Pool 1,,Pool 6,18,Pen - 2nd time point,Pen,2nd time point,210838,60535,60523,13680789,13192312,488477,0.0357,11212300,Pen_39,P420126,P420126|02-11-2010,2/11/2010,Project_4,95,95,3,DOF_3,42,Feedlot_42(N=6),Feedlot_42,95,Pen_420126,P420126 2010-02-11,255,NA,95,0,,,NA,NA,,9002.555556,7672.555556,1330,7729.555556,12,7672.555556,0,24,12,3,1206,28,57,,NA,High total ADD exposure,High total tetracycline exposure,Low parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,High parenteral MLS exposure,No feed MLS exposure,High parenteral betalactams exposure,Low parenteral phenicol exposure,High parenteral fluoroquinolones exposure,High parenteral sulfonamide exposure
PE29,PE29,CCATCCTC,Pool 1,,Pool 6,19,Pen - 2nd time point,Pen,2nd time point,95639,26442,26329,12550326,12161506,388820,0.031,9939432,Pen_40,P420128,P420128|02-11-2010,2/11/2010,Project_4,86,86,3,DOF_3,42,Feedlot_42(N=6),Feedlot_42,86,Pen_420128,P420128 2010-02-11,270,NA,86,0,,,NA,NA,,10102,8820,1282,8847,0,8820,0,22,0,3,1221,9,27,,NA,High total ADD exposure,High total tetracycline exposure,Low parenteral tetracycline exposure,High feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,High parenteral betalactams exposure,Low parenteral phenicol exposure,High parenteral fluoroquinolones exposure,Medium parenteral sulfonamide exposure
PE3,PE3,AACTCACC,Pool 4,,Pool 6,20,Pen - 2nd time point,Pen,2nd time point,204476,33438,33369,20392844,19805318,587526,0.0288,16081106,Pen_3,P210321,P210321|11-10-2009,11/10/2009,Project_4,77,77,3,DOF_3,21,Feedlot_21(N=24),Feedlot_21,77,Pen_210321,P210321 2009-11-10,9,NA,78,0,,,NA,NA,,328,328,0,328,0,328,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE30,PE30,CTAAGGTC,Pool 1,,Pool 6,21,Pen - 2nd time point,Pen,2nd time point,206102,54367,54338,18434389,17738591,695798,0.0377,16819529,Pen_16,P210360,P210360|02-26-2010,2/26/2010,Project_4,141,141,4,DOF_4,21,Feedlot_21(N=24),Feedlot_21,141,Pen_210360,P210360 2010-02-26,151,215,141,74,,,NA,NA,,2159.047222,1466.047222,693,2015.222222,33.825,1444.222222,21.825,5,12,12,90,3,571,,NA,High total ADD exposure,High total tetracycline exposure,High parenteral tetracycline exposure,High feed tetracycline exposure,High total MLS exposure,High parenteral MLS exposure,High feed MLS exposure,Low parenteral betalactams exposure,Medium parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,Low parenteral sulfonamide exposure
PE31,PE31,CATCAAGT,Pool 4,,Pool 6,22,Pen - 2nd time point,Pen,2nd time point,212619,50124,50091,22441037,21761975,679062,0.0303,17338344,Pen_17,P210361,P210361|02-26-2010,2/26/2010,Project_4,141,141,4,DOF_4,21,Feedlot_21(N=24),Feedlot_21,141,Pen_210361,P210361 2010-02-26,72,196,141,54,,,NA,NA,,1108.251389,763.2513889,345,1060.888889,11.3625,751.8888889,11.3625,6,0,0,30,0,309,,NA,High total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,Medium total MLS exposure,No parenteral MLS exposure,Medium feed MLS exposure,Low parenteral betalactams exposure,No parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE32,PE32,AAGGTACA,Pool 4,,Pool 6,23,Pen - 2nd time point,Pen,2nd time point,140657,39556,39556,25456702,24669873,786829,0.0309,20003335,Pen_18,P210362,P210362|02-26-2010,2/26/2010,Project_4,141,141,4,DOF_4,21,Feedlot_21(N=24),Feedlot_21,141,Pen_210362,P210362 2010-02-26,80,207,141,65,,,NA,NA,,1344.061111,937.0611111,407,1288.111111,19.95,923.1111111,13.95,0,6,0,33,3,365,,NA,High total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,High total MLS exposure,Medium parenteral MLS exposure,High feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,Low parenteral sulfonamide exposure
PE33,PE33,ATAGCGAC,Pool 4,,Pool 6,24,Pen - 2nd time point,Pen,2nd time point,211518,51242,51242,20318226,19625304,692922,0.0341,18082759,Pen_25,P210379,P210379|03-16-2010,3/16/2010,Project_4,144,144,4,DOF_4,21,Feedlot_21(N=24),Feedlot_21,144,Pen_210379,P210379 2010-03-16,112,200,144,56,,,NA,NA,,1897.4625,1316.4625,581,1814.5,20.9625,1301.5,14.9625,9,6,0,48,5,513,,NA,High total ADD exposure,Medium total tetracycline exposure,High parenteral tetracycline exposure,High feed tetracycline exposure,High total MLS exposure,Medium parenteral MLS exposure,High feed MLS exposure,Medium parenteral betalactams exposure,No parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,Low parenteral sulfonamide exposure
PE34,PE34,ACGCTCGA,Pool 4,,Pool 6,25,Pen - 2nd time point,Pen,2nd time point,206879,63179,63179,14988063,14453478,534585,0.0357,12686507,Pen_26,P210380,P210380|03-18-2010,3/18/2010,Project_4,142,142,4,DOF_4,21,Feedlot_21(N=24),Feedlot_21,142,Pen_210380,P210380 2010-03-18,46,NA,142,0,,,NA,NA,,666.4916667,600.4916667,66,611.6666667,9.825,593.6666667,6.825,3,3,0,39,3,18,,NA,Medium total ADD exposure,Medium total tetracycline exposure,Low parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,Low parenteral MLS exposure,Low feed MLS exposure,Low parenteral betalactams exposure,No parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,Low parenteral sulfonamide exposure
PE35,PE35,CTCAATGA,Pool 4,,Pool 6,26,Pen - 2nd time point,Pen,2nd time point,217120,59860,59860,15013056,14446075,566981,0.0378,12543970,Pen_27,P210381,P210381|03-18-2010,3/18/2010,Project_4,142,142,4,DOF_4,21,Feedlot_21(N=24),Feedlot_21,142,Pen_210381,P210381 2010-03-18,40,202,142,59,,,NA,NA,,564.3,554.3,10,548,6.3,548,6.3,4,0,0,3,3,0,,NA,Medium total ADD exposure,Medium total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,Low parenteral betalactams exposure,No parenteral phenicol exposure,Low parenteral fluoroquinolones exposure,Low parenteral sulfonamide exposure
PE36,PE36,TCCGTCTA,Pool 4,,Pool 6,27,Pen - 2nd time point,Pen,2nd time point,179664,53362,53347,11422713,11043192,379521,0.0332,9373784,Pen_28,P210389,P210389|03-18-2010,3/18/2010,Project_4,133,133,4,DOF_4,21,Feedlot_21(N=24),Feedlot_21,133,Pen_210389,P210389 2010-03-18,22,NA,133,0,,,NA,NA,,446.8444444,314.8444444,132,436.4444444,4.4,310.4444444,4.4,0,0,0,6,0,126,,NA,Medium total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,Low parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE37,PE37,AGATGTAC,Pool 1,,Pool 6,28,Pen - 2nd time point,Pen,2nd time point,200111,57352,57352,14473202,13980445,492757,0.034,12075860,Pen_37,L310316,L310316|03-19-2010,3/19/2010,Project_4,64,64,2,DOF_2,31,Feedlot_31(N=9),Feedlot_31,64,Pen_310316,L310316 2010-03-19,60,88,65,24,,,NA,NA,,1311,1300,11,1308,0,1300,0,3,0,0,0,0,8,,NA,High total ADD exposure,Medium total tetracycline exposure,Low parenteral tetracycline exposure,High feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,Low parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE38,PE38,TCTTCACA,Pool 2,,Pool 6,29,Pen - 2nd time point,Pen,2nd time point,203374,56975,56905,16334138,15511640,822498,0.0504,12927247,Pen_36,P050189,P050189|03-22-2010,3/22/2010,Project_4,74,74,3,DOF_3,5,Feedlot_5(N=5),Feedlot_5,74,Pen_50189,P050189 2010-03-22,100,NA,74,0,,,NA,NA,,2039.777778,1138.777778,901,1988.777778,12,1138.777778,0,3,12,0,36,0,850,,NA,High total ADD exposure,Medium total tetracycline exposure,High parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,High parenteral MLS exposure,No feed MLS exposure,Low parenteral betalactams exposure,No parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE39,PE39,CCGAAGTA,Pool 2,,Pool 6,30,Pen - 2nd time point,Pen,2nd time point,206855,81136,81128,16984631,15928258,1056373,0.0622,14214885,Pen_35,L310315,L310315|03-23-2010,3/23/2010,Project_4,69,69,2,DOF_2,31,Feedlot_31(N=9),Feedlot_31,69,Pen_310315,L310315 2010-03-23,79,124,70,55,,,NA,NA,,1065,700,365,1062,0,700,0,0,0,0,0,3,362,,NA,Medium total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,Low parenteral sulfonamide exposure
PE4,PE4,GCTAACGA,Pool 4,,Pool 6,31,Pen - 2nd time point,Pen,2nd time point,200890,38365,38365,16603644,16097593,506051,0.0305,12734039,Pen_6,P210326,P210326|11-10-2009,11/10/2009,Project_4,68,68,2,DOF_2,21,Feedlot_21(N=24),Feedlot_21,68,Pen_210326,P210326 2009-11-10,33,99,68,0,,,NA,NA,,344.5777778,344.5777778,0,334.7777778,9.8,334.7777778,9.8,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Medium feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE41,PE41,CGACACAC,Pool 1,,Pool 6,32,Pen - 2nd time point,Pen,2nd time point,217312,47322,47201,10757992,10399014,358978,0.0334,8816776,Pen_38,P050191,P050191|03-23-2010,3/23/2010,Project_4,68,68,2,DOF_2,5,Feedlot_5(N=5),Feedlot_5,68,Pen_50191,P050191 2010-03-23,96,NA,75,0,,,NA,NA,,2176.5,1237.5,939,2139.5,0,1237.5,0,16,0,0,3,18,902,,NA,High total ADD exposure,High total tetracycline exposure,High parenteral tetracycline exposure,High feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,High parenteral betalactams exposure,No parenteral phenicol exposure,Low parenteral fluoroquinolones exposure,High parenteral sulfonamide exposure
PE42,PE42,CGCATACA,Pool 2,,Pool 6,33,Pen - 2nd time point,Pen,2nd time point,201411,49164,49164,13160352,12264992,895360,0.068,10089221,Pen_30,P210397,P210397|03-25-2010,3/25/2010,Project_4,132,132,4,DOF_4,21,Feedlot_21(N=24),Feedlot_21,132,Pen_210397,P210397 2010-03-25,32,NA,133,0,,,NA,NA,,561.55,540.55,21,532,11.55,532,8.55,0,3,0,18,0,0,,NA,Medium total ADD exposure,Medium total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,Medium total MLS exposure,Low parenteral MLS exposure,Medium feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE43,PE43,ATGCCTAA,Pool 2,,Pool 6,34,Pen - 2nd time point,Pen,2nd time point,213548,61154,61154,17373341,16315254,1058087,0.0609,13983053,Pen_31,P210399,P210399|03-25-2010,3/25/2010,Project_4,133,133,4,DOF_4,21,Feedlot_21(N=24),Feedlot_21,133,Pen_210399,P210399 2010-03-25,103,186,133,53,,,NA,NA,,904.0375,761.0375,143,793,18.0375,749,12.0375,6,6,0,57,30,44,,NA,Medium total ADD exposure,Medium total tetracycline exposure,Low parenteral tetracycline exposure,Medium feed tetracycline exposure,High total MLS exposure,Medium parenteral MLS exposure,Medium feed MLS exposure,Low parenteral betalactams exposure,No parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,High parenteral sulfonamide exposure
PE44,PE44,AGGCTAAC,Pool 4,,Pool 6,35,Pen - 2nd time point,Pen,2nd time point,216177,47389,47369,19137749,18472635,665114,0.0348,17161451,Pen_41,P210424,P210424|04-01-2010,4/1/2010,Project_4,79,79,3,DOF_3,21,Feedlot_21(N=24),Feedlot_21,79,Pen_210424,P210424 2010-04-01,68,125,79,46,,,NA,NA,,1025.3125,596.3125,429,1012.5,8.8125,587.5,8.8125,4,0,0,0,0,425,,NA,Medium total ADD exposure,Medium total tetracycline exposure,High parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Medium feed MLS exposure,Low parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE45,PE45,CCATCCTC,Pool 4,,Pool 6,36,Pen - 2nd time point,Pen,2nd time point,214722,58763,58612,18328123,17777958,550165,0.03,14574997,Pen_29,P210401,P210401|04-08-2010,4/8/2010,Project_4,140,140,4,DOF_4,21,Feedlot_21(N=24),Feedlot_21,140,Pen_210401,P210401 2010-04-08,51,179,140,39,,,NA,NA,,1054.588889,1033.588889,21,1019.888889,13.7,1019.888889,13.7,0,0,0,18,3,0,,NA,Medium total ADD exposure,Medium total tetracycline exposure,No parenteral tetracycline exposure,High feed tetracycline exposure,Medium total MLS exposure,No parenteral MLS exposure,High feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,Low parenteral sulfonamide exposure
PE46,PE46,AGATGTAC,Pool 4,,Pool 6,37,Pen - 2nd time point,Pen,2nd time point,214006,63965,63942,21301375,20599212,702163,0.033,17723107,Pen_32,P210417,P210417|04-08-2010,4/8/2010,Project_4,127,127,4,DOF_4,21,Feedlot_21(N=24),Feedlot_21,127,Pen_210417,P210417 2010-04-08,67,166,127,39,,,NA,NA,,1104.879167,755.8791667,349,746.1666667,9.7125,746.1666667,9.7125,10,0,6,333,0,0,,NA,High total ADD exposure,Medium total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Medium feed MLS exposure,Medium parenteral betalactams exposure,Medium parenteral phenicol exposure,High parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE47,PE47,TCTTCACA,Pool 4,,Pool 6,38,Pen - 2nd time point,Pen,2nd time point,209128,47782,47730,14405735,13953678,452057,0.0314,11613682,Pen_33,P210418,P210418|04-08-2010,4/8/2010,Project_4,126,126,4,DOF_4,21,Feedlot_21(N=24),Feedlot_21,126,Pen_210418,P210418 2010-04-08,64,165,126,39,,,NA,NA,,782.9680556,537.9680556,245,531.0555556,6.9125,531.0555556,6.9125,8,0,0,237,0,0,,NA,Medium total ADD exposure,Medium total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,Medium parenteral betalactams exposure,No parenteral phenicol exposure,High parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE48,PE48,CCGAAGTA,Pool 4,,Pool 6,39,Pen - 2nd time point,Pen,2nd time point,210815,52862,52837,21461477,20781171,680306,0.0317,16863284,Pen_34,P210422,P210422|04-20-2010,4/20/2010,Project_4,132,132,4,DOF_4,21,Feedlot_21(N=24),Feedlot_21,132,Pen_210422,P210422 2010-04-20,94,159,132,27,,,NA,NA,,1637.1,1143.1,494,1137,16.1,1127,16.1,1,0,0,483,0,10,,NA,High total ADD exposure,Medium total tetracycline exposure,Low parenteral tetracycline exposure,High feed tetracycline exposure,High total MLS exposure,No parenteral MLS exposure,High feed MLS exposure,Low parenteral betalactams exposure,No parenteral phenicol exposure,High parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE5,PE5,CAGATCTG,Pool 4,,Pool 6,40,Pen - 2nd time point,Pen,2nd time point,201779,35415,35415,14315547,13893309,422238,0.0295,11022885,Pen_2,P310211,P310211|11-12-2009,11/12/2009,Project_4,84,84,3,DOF_3,31,Feedlot_31(N=9),Feedlot_31,84,Pen_310211,P310211 2009-11-12,75,NA,84,0,,,NA,NA,,1322.333333,905.3333333,417,1303.333333,0,905.3333333,0,10,0,0,0,9,398,,NA,High total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,Medium parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,Medium parenteral sulfonamide exposure
PE50,PE50,CGCATACA,Pool 4,,Pool 6,41,Pen - 2nd time point,Pen,2nd time point,213653,65150,65150,15033985,14271825,762160,0.0507,12724449,Pen_44,P210336,P210336|09-10-2009,9/10/2009,Project_4,2,2,1,DOF_1,21,Feedlot_21(N=24),Feedlot_21,112,Pen_210336,P210336 2009-09-10,72,NA,1,110,,,NA,NA,,9.888888889,9.888888889,0,9.888888889,0,9.888888889,0,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Low feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE51,PE51,AATGTTGC,Pool 4,,Pool 6,42,Pen - 2nd time point,Pen,2nd time point,175362,44874,44692,19237624,18579081,658543,0.0342,18504184,Pen_42,P210323,P210323|11-10-2009,11/10/2009,Project_4,77,77,3,DOF_3,21,Feedlot_21(N=24),Feedlot_21,77,Pen_210323,P210323 2009-11-10,11,NA,74,0,,,NA,NA,,286.6666667,283.6666667,3,283.6666667,0,283.6666667,0,0,0,0,0,3,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,Low parenteral sulfonamide exposure
PE52,PE52,TGAAGAGA,Pool 4,,Pool 6,43,Pen - 2nd time point,Pen,2nd time point,204758,44950,44919,19299089,18581227,717862,0.0372,16875239,Pen_43,P050168,P050168|12-29-2009,12/29/2009,Project_4,81,81,3,DOF_3,5,Feedlot_5(N=5),Feedlot_5,81,Pen_50168,P050168 2009-12-29,42,NA,80,0,,,NA,NA,,725.1111111,671.1111111,54,671.1111111,6,671.1111111,0,36,6,3,9,0,0,,NA,Medium total ADD exposure,Medium total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,Medium parenteral MLS exposure,No feed MLS exposure,High parenteral betalactams exposure,Low parenteral phenicol exposure,Low parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE7,PE7,ATCCTGTA,Pool 4,,Pool 6,44,Pen - 2nd time point,Pen,2nd time point,211284,72073,72073,17873184,17314678,558506,0.0312,14380397,Pen_4,P310218,P310218|11-16-2009,11/16/2009,Project_4,74,74,3,DOF_3,31,Feedlot_31(N=9),Feedlot_31,74,Pen_310218,P310218 2009-11-16,86,138,75,64,,,NA,NA,,1129.333333,708.3333333,421,1066.333333,0,708.3333333,0,21,0,0,42,0,358,,NA,High total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,High parenteral betalactams exposure,No parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PE9,PE9,CTGTAGCC,Pool 4,,Pool 6,45,Pen - 2nd time point,Pen,2nd time point,204642,52234,52226,14920293,14468008,452285,0.0303,11344741,Pen_5,P050156,P050156|11-24-2009,11/24/2009,Project_4,75,75,3,DOF_3,5,Feedlot_5(N=5),Feedlot_5,75,Pen_50156,P050156 2009-11-24,78,NA,75,0,,,NA,NA,,1297.833333,1220.833333,77,1224.833333,6,1220.833333,0,46,6,6,9,6,4,,NA,High total ADD exposure,Medium total tetracycline exposure,Low parenteral tetracycline exposure,High feed tetracycline exposure,Low total MLS exposure,Medium parenteral MLS exposure,No feed MLS exposure,High parenteral betalactams exposure,Medium parenteral phenicol exposure,Low parenteral fluoroquinolones exposure,Medium parenteral sulfonamide exposure
PS1,PS1,AAGGTACA,Pool 6,,Pool 6,1,Pen - 3rd time point,Pen,3rd time point,205425,54226,54209,20613785,19903805,709980,0.0344,15590163,Pen_1,P210319,P210319|12-11-2009,12/11/2009,Project_4,120,120,3,DOF_3,21,Feedlot_21_shipment(N=7),Feedlot_21,89,Pen_210319,P210319 2009-12-11,51,120,115,-1,,,NA,NA,,903.625,895.625,8,877,20.625,875,20.625,6,0,0,0,0,2,,NA,Medium total ADD exposure,Medium total tetracycline exposure,Low parenteral tetracycline exposure,Medium feed tetracycline exposure,High total MLS exposure,No parenteral MLS exposure,High feed MLS exposure,Low parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PS11,PS11,TAGGATGA,Pool 1,,Pool 6,2,Pen - 3rd time point,Pen,3rd time point,188861,57893,57881,15709036,15163390,545646,0.0347,14608699,Pen_18,P210362,P210362|05-03-2010,5/3/2010,Project_4,207,207,5,DOF_5,21,Feedlot_21_shipment(N=7),Feedlot_21,141,Pen_210362,P210362 2010-05-03,80,207,207,-1,,,NA,NA,,1760.244444,1352.244444,408,1692.444444,30.8,1327.444444,24.8,1,6,0,33,3,365,,NA,High total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,High feed tetracycline exposure,High total MLS exposure,Medium parenteral MLS exposure,High feed MLS exposure,Low parenteral betalactams exposure,No parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,Low parenteral sulfonamide exposure
PS12,PS12,CACTTCGA,Pool 2,,Pool 6,3,Pen - 3rd time point,Pen,3rd time point,203682,51993,51964,15199411,14473307,726104,0.0478,11506515,Pen_25,P210379,P210379|05-11-2010,5/11/2010,Project_4,200,200,5,DOF_5,21,Feedlot_21_shipment(N=7),Feedlot_21,144,Pen_210379,P210379 2010-05-11,112,200,200,0,,,NA,NA,,2434.4625,1848.4625,586,2348.5,20.9625,1833.5,14.9625,12,6,0,48,5,515,,NA,High total ADD exposure,High total tetracycline exposure,High parenteral tetracycline exposure,High feed tetracycline exposure,High total MLS exposure,Medium parenteral MLS exposure,High feed MLS exposure,Medium parenteral betalactams exposure,No parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,Low parenteral sulfonamide exposure
PS2,PS2,CCGTGAGA,Pool 1,,Pool 6,4,Pen - 3rd time point,Pen,3rd time point,206228,56843,56835,13148475,12683065,465410,0.0354,11040977,Pen_6,P210326,P210326|12-11-2009,12/11/2009,Project_4,99,99,3,DOF_3,21,Feedlot_21_shipment(N=7),Feedlot_21,68,Pen_210326,P210326 2009-12-11,33,99,99,-31,,,NA,NA,,349.4666667,349.4666667,0,339.6666667,9.8,339.6666667,9.8,0,0,0,0,0,0,,NA,Low total ADD exposure,Low total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Medium feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PS3,PS3,GTGTTCTA,Pool 1,,Pool 6,5,Pen - 3rd time point,Pen,3rd time point,129087,36627,36614,13321580,12814782,506798,0.038,11679552,Pen_4,P310218,P310218|01-19-2010,1/19/2010,Project_4,138,138,4,DOF_4,31,Feedlot_31(N=9),Feedlot_31,74,Pen_310218,P310218 2010-01-19,86,138,139,0,,,NA,NA,,1352.847222,924.8472222,428,1170.222222,112.625,812.2222222,112.625,28,0,0,42,0,358,,NA,High total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,High total MLS exposure,No parenteral MLS exposure,High feed MLS exposure,High parenteral betalactams exposure,No parenteral phenicol exposure,Medium parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PS4,PS4,CAATGGAA,Pool 2,,Pool 6,6,Pen - 3rd time point,Pen,3rd time point,205454,54612,54579,14531093,13878706,652387,0.0449,12334629,Pen_20,P310262,P310262|02-01-2010,2/1/2010,Project_4,94,94,3,DOF_3,31,Feedlot_31(N=9),Feedlot_31,83,Pen_310262,P310262 2010-02-01,50,94,96,0,,,NA,NA,,1346.333333,965.3333333,381,1329.333333,0,965.3333333,0,0,0,3,0,14,364,,NA,High total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,No total MLS exposure,No parenteral MLS exposure,No feed MLS exposure,No parenteral betalactams exposure,Low parenteral phenicol exposure,No parenteral fluoroquinolones exposure,Medium parenteral sulfonamide exposure
PS5,PS5,AGCACCTC,Pool 2,,Pool 6,7,Pen - 3rd time point,Pen,3rd time point,219918,46496,46414,18304021,17589335,714686,0.039,14038719,Pen_15,P210359,P210359|02-08-2010,2/8/2010,Project_4,125,125,4,DOF_4,21,Feedlot_21_shipment(N=7),Feedlot_21,106,Pen_210359,P210359 2010-02-08,21,125,125,-19,,,NA,NA,,423.1972222,423.1972222,0,417.7222222,5.475,417.7222222,5.475,0,0,0,0,0,0,,NA,Medium total ADD exposure,Medium total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Low feed MLS exposure,No parenteral betalactams exposure,No parenteral phenicol exposure,No parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
PS6,PS6,CAGCGTTA,Pool 1,,Pool 6,8,Pen - 3rd time point,Pen,3rd time point,218821,58207,58207,15993215,15456393,536822,0.0336,15424507,Pen_21,P310263,P310263|02-24-2010,2/24/2010,Project_4,117,117,3,DOF_3,31,Feedlot_31(N=9),Feedlot_31,83,Pen_310263,P310263 2010-02-24,90,117,117,0,,,NA,NA,,1380.593131,1000.022222,380.5709091,1320.222222,41.8,958.2222222,41.8,3,0,0,9.570909091,6,362,,NA,High total ADD exposure,Medium total tetracycline exposure,Medium parenteral tetracycline exposure,Medium feed tetracycline exposure,High total MLS exposure,No parenteral MLS exposure,High feed MLS exposure,Low parenteral betalactams exposure,No parenteral phenicol exposure,Low parenteral fluoroquinolones exposure,Medium parenteral sulfonamide exposure
PS8,PS8,GAATCTGA,Pool 2,,Pool 6,9,Pen - 3rd time point,Pen,3rd time point,213157,71908,71908,11279681,10614287,665394,0.059,9059887,Pen_13,P210350,P210350|03-18-2010,3/18/2010,Project_4,177,177,4,DOF_4,21,Feedlot_21_shipment(N=7),Feedlot_21,127,Pen_210350,P210350 2010-03-18,136,177,177,0,,,NA,NA,,2520.3875,1850.3875,670,1881.5,25.8875,1833.5,16.8875,10,9,18,582,3,48,,NA,High total ADD exposure,Medium total tetracycline exposure,Low parenteral tetracycline exposure,High feed tetracycline exposure,High total MLS exposure,Medium parenteral MLS exposure,High feed MLS exposure,Medium parenteral betalactams exposure,High parenteral phenicol exposure,High parenteral fluoroquinolones exposure,Low parenteral sulfonamide exposure
PS9,PS9,AACGTGAT,Pool 2,,Pool 6,10,Pen - 3rd time point,Pen,3rd time point,214865,49111,49043,6192389,5827204,365185,0.059,5155319,Pen_8,P210340,P210340|04-19-2010,4/19/2010,Project_4,222,222,5,DOF_5,21,Feedlot_21_shipment(N=7),Feedlot_21,140,Pen_210340,P210340 2010-04-19,36,222,222,-1,,,NA,NA,,928.5194444,920.5194444,8,911.9444444,8.575,911.9444444,8.575,5,0,0,3,0,0,,NA,Medium total ADD exposure,Medium total tetracycline exposure,No parenteral tetracycline exposure,Medium feed tetracycline exposure,Low total MLS exposure,No parenteral MLS exposure,Medium feed MLS exposure,Low parenteral betalactams exposure,No parenteral phenicol exposure,Low parenteral fluoroquinolones exposure,No parenteral sulfonamide exposure
